Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Dermatology

  Free Subscription


Articles published in J Dermatol

Retrieve available abstracts of 440 articles:
HTML format



Single Articles


    January 2023
  1. LIU N, Zhang C, Hua W
    Dietary inflammatory potential and psoriasis: A cross-sectional study.
    J Dermatol. 2023 Jan 26. doi: 10.1111/1346-8138.16731.
    PubMed     Abstract available


  2. DE DECKER I, Loge T, Hoeksema H, Speeckaert MM, et al
    Dissolving microneedles for effective and painless intradermal drug delivery in various skin conditions: A systematic review.
    J Dermatol. 2023 Jan 26. doi: 10.1111/1346-8138.16732.
    PubMed     Abstract available


  3. YOSHIZAKI A, Fujii K, Kanekura T
    Neutrophilic sebaceous adenitis treated successfully with diaminodiphenyl sulfone.
    J Dermatol. 2023 Jan 26. doi: 10.1111/1346-8138.16735.
    PubMed    


  4. OHATA C, Anezaki H, Kaneko S, Okazaki F, et al
    Clinical characteristics of patients with psoriasis with family history: A multicenter observational study.
    J Dermatol. 2023 Jan 24. doi: 10.1111/1346-8138.16733.
    PubMed     Abstract available


  5. UEDA M, Kogame T, Egawa G, Kambe N, et al
    A case of Kimura disease with atopic dermatitis successfully treated with baricitinib.
    J Dermatol. 2023 Jan 20. doi: 10.1111/1346-8138.16724.
    PubMed    


  6. YUSHARYAHYA SN, Japranata VV, Jonlean R, Legiawati L, et al
    Cutaneous manifestations in elderly patients with confirmed coronavirus disease 2019 and the disease outcomes: A systematic review.
    J Dermatol. 2023 Jan 20. doi: 10.1111/1346-8138.16722.
    PubMed     Abstract available


  7. WANG WM, Jin HZ
    Biologics in pediatric psoriasis.
    J Dermatol. 2023 Jan 18. doi: 10.1111/1346-8138.16702.
    PubMed     Abstract available


  8. MURAKAMI T, Aozasa N, Fukano H, Miyamoto Y, et al
    Successful treatment of cutaneous Mycobacterium chelonae infection by switching from levofloxacin to sitafloxacin.
    J Dermatol. 2023 Jan 18. doi: 10.1111/1346-8138.16720.
    PubMed    


  9. KAMIYA S, Koizumi H, Suzuki Y, Imai S, et al
    Cutaneous manifestations of microscopic polyangiitis successfully controlled with avacopan alone.
    J Dermatol. 2023 Jan 18. doi: 10.1111/1346-8138.16726.
    PubMed    


  10. NAKASHIMA C, Kato M, Otsuka A
    Cutaneous manifestations of COVID-19 and COVID-19 vaccination.
    J Dermatol. 2023 Jan 13. doi: 10.1111/1346-8138.16651.
    PubMed     Abstract available


  11. FUJITA Y, Sugai T, Maya Y, Inamura E, et al
    Secukinumab-induced oral lichen planus in a psoriatic arthritis patient ameliorated after a switch to risankizumab.
    J Dermatol. 2023 Jan 11. doi: 10.1111/1346-8138.16719.
    PubMed     Abstract available


  12. TADA Y, Itakura A, Hosono K, Kawamura T, et al
    Psoriasis patient preferences for the use of biologics during the coronavirus era.
    J Dermatol. 2023 Jan 11. doi: 10.1111/1346-8138.16703.
    PubMed     Abstract available


  13. KISHIBE M, Koike K, Kanno K, Ishida-Yamamoto A, et al
    Autoimmunity-related neutrophilic dermatosis after coronavirus disease 2019 vaccination: A case report and literature review.
    J Dermatol. 2023 Jan 5. doi: 10.1111/1346-8138.16718.
    PubMed     Abstract available


  14. SHIMIZU A, Yamaguchi R, Kuriyama Y
    Recent advances in cutaneous HPV infection.
    J Dermatol. 2023 Jan 5. doi: 10.1111/1346-8138.16697.
    PubMed     Abstract available


  15. MALAURE C, Hoang S, Bagny K, Tauziede-Espariat A, et al
    Multifocal cutaneous phaeohyphomycosis caused by Paraconiothyrium cyclothyrioides in an immunocompromised patient: A case report.
    J Dermatol. 2023 Jan 5. doi: 10.1111/1346-8138.16706.
    PubMed    


  16. SUZUKI H, Hashimoto T, Sugiura R, Ogata H, et al
    Disseminated cutaneous hyalohyphomycosis caused by Fusarium proliferatum in a patient with aplastic anemia.
    J Dermatol. 2023 Jan 5. doi: 10.1111/1346-8138.16708.
    PubMed    


  17. ARANISHI T, Ito T, Fukuyama M, Isaka Y, et al
    Prevalence of alopecia areata in Japan: Estimates from a nationally representative sample.
    J Dermatol. 2023;50:26-36.
    PubMed     Abstract available


  18. CAMPOS-ALBERTO E, Hirose T, Napatalung L, Ohyama M, et al
    Prevalence, comorbidities, and treatment patterns of Japanese patients with alopecia areata: A descriptive study using Japan medical data center claims database.
    J Dermatol. 2023;50:37-45.
    PubMed     Abstract available


  19. MAE K, Kawakami Y, Kajita A, Takeichi T, et al
    Novel homozygous missense mutation c.1654G>T in the ALOX12B gene causing congenital ichthyosiform erythroderma.
    J Dermatol. 2023;50:e37-e38.
    PubMed    


  20. MAEDA T, Nagai K, Uehara J, Toyoshima R, et al
    Sentinel lymph node biopsy in extramammary Paget disease: A 13-year institutional experience.
    J Dermatol. 2023;50:57-63.
    PubMed     Abstract available


  21. KAGEYAMA R, Ito T, Nakazawa S, Shimauchi T, et al
    A case of telogen effluvium followed by alopecia areata after SARS-CoV-2 infection.
    J Dermatol. 2023;50:e32-e34.
    PubMed    


  22. IMURA K, Furuya K, Masuda Y, Sano Y, et al
    Nontyphoidal Salmonella subcutaneous chest wall abscess with costal osteomyelitis.
    J Dermatol. 2023;50:e35-e36.
    PubMed    


  23. KOIZUMI H, Muro Y, Imai S, Yamashita Y, et al
    A case of juvenile amyopathic dermatomyositis with anti-transcription intermediary factor 1-alpha antibody showing negative anti-TIF1-gamma ELISA results: Comment on "Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary f
    J Dermatol. 2023;50:e39-e40.
    PubMed    


  24. SANO Y, Ide K, Hasegawa T, Honda T, et al
    A case of localized pruritus on the left lower leg in a patient with spinal glioma.
    J Dermatol. 2023;50:e30-e31.
    PubMed    


  25. ARAKAWA H, Adachi T, Kobayashi Y, Inazumi T, et al
    A severe case of hidradenitis suppurativa with chronic anemia treated with adalimumab.
    J Dermatol. 2023;50:e22-e23.
    PubMed    


    December 2022
  26. YATSUZUKA K, Matsumoto T, Sakane Y, Fukaura R, et al
    The use of certolizumab pegol to successfully treat generalized pustular psoriasis combined with psoriatic uveitis.
    J Dermatol. 2022 Dec 30. doi: 10.1111/1346-8138.16704.
    PubMed    


  27. MIKAMI H, Akasaka E, Nakano H, Sawamura D, et al
    Eruptive melanocytic nevi associated with encorafenib and cetuximab combination therapy.
    J Dermatol. 2022 Dec 30. doi: 10.1111/1346-8138.16701.
    PubMed    


  28. ONITSUKA M, Farooq M, Iqbal MN, Yasuno S, et al
    A homozygous loss-of-function variant in the MPO gene is associated with generalized pustular psoriasis.
    J Dermatol. 2022 Dec 30. doi: 10.1111/1346-8138.16700.
    PubMed     Abstract available


  29. SAEKI H, Mabuchi T, Asahina A, Abe M, et al
    English version of Japanese guidance for use of biologics for psoriasis (the 2022 version).
    J Dermatol. 2022 Dec 29. doi: 10.1111/1346-8138.16691.
    PubMed     Abstract available


  30. HAN J, Stratman S, Young JN, Poplausky D, et al
    Unique protein signatures evolve during the course of a delayed-type hypersensitivity reaction in human skin.
    J Dermatol. 2022 Dec 28. doi: 10.1111/1346-8138.16688.
    PubMed     Abstract available


  31. MELIN A, Bouchereau S, Guelimi R, Bergqvist C, et al
    Safety and efficacy of high-dose clobetasol propionate 0.05% in cutaneous lichen planus.
    J Dermatol. 2022 Dec 28. doi: 10.1111/1346-8138.16689.
    PubMed     Abstract available


  32. LI J, Wen W, Mu Z, Du X, et al
    Prevalence of cutaneous manifestations in COVID-19: A meta-analysis.
    J Dermatol. 2022 Dec 20. doi: 10.1111/1346-8138.16672.
    PubMed     Abstract available


  33. SUZUKI M, Koshikawa S, Watanabe H, Inomata N, et al
    Elevated serum osteopontin levels in patients with severe cutaneous adverse drug reactions.
    J Dermatol. 2022 Dec 20. doi: 10.1111/1346-8138.16670.
    PubMed     Abstract available


  34. HONMA M, Kanai Y, Murotani K, Ito K, et al
    Effectiveness of brodalumab in improving itching and skin pain in Japanese patients with psoriasis: The ProLOGUE study.
    J Dermatol. 2022 Dec 20. doi: 10.1111/1346-8138.16682.
    PubMed     Abstract available


  35. CHEN G, Wang M, Wang P, Liang B, et al
    An intronic splice-site variant in MBTPS2 underlies ichthyosis follicularis with atrichia and photophobia syndrome.
    J Dermatol. 2022 Dec 20. doi: 10.1111/1346-8138.16684.
    PubMed     Abstract available


  36. TAKAI S, Arai E, Shojiguchi N, Nakamura Y, et al
    Application of fluorescence in situ hybridization in distinguishing acral melanoma in situ from acral junctional melanocytic nevus on the volar skin in Japanese patients.
    J Dermatol. 2022 Dec 20. doi: 10.1111/1346-8138.16681.
    PubMed     Abstract available


  37. NAKAMURA K, Ashida A, Kiniwa Y, Okuyama R, et al
    Analysis of immune-related adverse events correlated with good prognosis in melanoma treatment and fluctuating blood factors.
    J Dermatol. 2022 Dec 20. doi: 10.1111/1346-8138.16692.
    PubMed    


  38. YOKOI K, Watanabe R, Kume M, Yamane S, et al
    Melanocyte-specific CD49a(+) CD8(+) T cells in vitiligo lesion potentiate to maintain activity during systemic steroid therapy.
    J Dermatol. 2022 Dec 14. doi: 10.1111/1346-8138.16680.
    PubMed     Abstract available


  39. YAMANAKA K, Okubo Y, Yasuda I, Saito N, et al
    Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study.
    J Dermatol. 2022 Dec 13. doi: 10.1111/1346-8138.16667.
    PubMed     Abstract available


  40. KAWAKAMI T, Yokoyama K, Ikeda T, Tomizawa H, et al
    Presence of eosinophil extracellular trap cell death in the affected skin of eosinophilic granulomatosis with polyangiitis.
    J Dermatol. 2022 Dec 13. doi: 10.1111/1346-8138.16656.
    PubMed     Abstract available


  41. TAKAHASHI A, Namikawa K, Ogata D, Jinnai S, et al
    Updated analysis of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma.
    J Dermatol. 2022 Dec 13. doi: 10.1111/1346-8138.16669.
    PubMed     Abstract available


  42. ISHIKAWA M, Yamamoto T
    Interstitial granulomatous dermatitis in a patient with systemic lupus erythematosus presenting with rope sign.
    J Dermatol. 2022 Dec 13. doi: 10.1111/1346-8138.16674.
    PubMed    


  43. YU L, Wei L, Ma L, Li L, et al
    First report of oral atenolol for treatment of kaposiform hemangioendothelioma, a viable alternative to propranolol.
    J Dermatol. 2022 Dec 10. doi: 10.1111/1346-8138.16657.
    PubMed    


  44. ZHANG Z, Yu K, Jiang Z, Liu O, et al
    Clinical value of the prognostic nutritional index and red blood cell distribution width-to-albumin ratio for the prediction of severity of and mortality associated with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2022 Dec 7. doi: 10.1111/1346-8138.16661.
    PubMed     Abstract available


  45. YAMASAKI K, Miyachi Y
    Perspectives on rosacea patient characteristics and quality of life using baseline data from a phase 3 clinical study conducted in Japan.
    J Dermatol. 2022;49:1221-1227.
    PubMed     Abstract available


  46. WALKER AM, Bermas BL, Jacobe HT
    Morphea disease activity during pregnancy: A case series.
    J Dermatol. 2022;49:1278-1283.
    PubMed     Abstract available


  47. KIKUCHI K, Katsuyama M, Yoshikawa T, Wakeshima N, et al
    Epidemiological survey of the quantity and anatomical position of facial pigmented spots in relation to age in 454 Japanese women.
    J Dermatol. 2022;49:1245-1254.
    PubMed     Abstract available


  48. NISHIBU A, Iwanaga T, Ushigami T, Mochizuki T, et al
    A case of hidrotic ectodermal dysplasia with developing eccrine syringofibroadenoma with heterozygous mutation of GJB6 gene.
    J Dermatol. 2022;49:e451-e452.
    PubMed    


  49. HASEGAWA T, Oyama N, Kasamatsu H, Chino T, et al
    Intertriginous erythema associated with enfortumab vedotin, a nectin-4-targeting antibody-drug conjugate, in a case with metastatic urothelial cancer: Immunohistochemical evidence for molecular-targeted eruption.
    J Dermatol. 2022;49:e453-e454.
    PubMed    


  50. SAITO R, Takahagi S, Nakano F, Furutani K, et al
    A survey on subtypes and clinical characteristics of 1061 patients with urticaria in the primary care institutes in Japan.
    J Dermatol. 2022;49:1255-1262.
    PubMed     Abstract available


  51. SANCHEZ-DIAZ M, Salvador-Rodriguez L, Cuenca-Barrales C, Arias-Santiago S, et al
    Exploring the role of systemic immune-inflammation index and neutrophil-lymphocyte ratio in cardiovascular risk stratification for patients with hidradenitis suppurativa: A cross-sectional study.
    J Dermatol. 2022;49:1238-1244.
    PubMed     Abstract available


  52. KASHIWADA-NAKAMURA K, Noguchi H, Hiruma M, Tanaka M, et al
    Dermoscopic findings of sporotrichosis manifesting as a punched-out ulcer.
    J Dermatol. 2022;49:e449-e450.
    PubMed    


  53. HIRAIWA T, Yamamoto T
    Survey of the treatment outcome of patients with pustulotic arthro-osteitis associated with palmoplantar pustulosis.
    J Dermatol. 2022;49:e448.
    PubMed    


  54. YANG J, Zeng J, Lu J
    Mechanisms of ultraviolet-induced melasma formation: A review.
    J Dermatol. 2022;49:1201-1210.
    PubMed     Abstract available


  55. XU X, Pradhan S, Zhang C, Ran Y, et al
    A case of infantile tinea of vellus hair confirmed by dermoscopy and scanning electron microscopy and detection of infected source.
    J Dermatol. 2022;49:1325-1329.
    PubMed     Abstract available


  56. IKEDA T, Yokoyama K, Kawakami T
    Overlapping acute generalized exanthematous pustulosis drug reaction with eosinophilia and systemic symptoms induced by a second dose of the Moderna COVID-19 vaccine.
    J Dermatol. 2022;49:e446-e447.
    PubMed    


  57. MINAMI Y, Okamoto T, Hirotsu Y, Amemiya K, et al
    Phakomatosis pigmentovascularis type IIb with Klippel-Trenaunay syndrome: Association with GNAQ mutation in vascular endothelial cells.
    J Dermatol. 2022;49:e444-e445.
    PubMed    


  58. SEISHIMA M, Sasaki M, Sugie S
    Successful treatment of pyoderma gangrenosum using adalimumab in a patient undergoing hemodialysis.
    J Dermatol. 2022;49:e435-e436.
    PubMed    


  59. UCHIYAMA A, Kosaka K, Okada K, Motegi SI, et al
    Possible suppressive effects of tranilast on NLRP3 inflammasome activation in necrobiosis lipoidica.
    J Dermatol. 2022;49:e433-e434.
    PubMed    


  60. KINOSHITA Y, Tateishi C, Sowa-Osako J, Kusutani N, et al
    Generalized granuloma annulare with large patches on the face.
    J Dermatol. 2022;49:e426-e427.
    PubMed    


    November 2022
  61. AKATSUKA T, Toyama T, Morimura S, Komuta M, et al
    A case of primary meningeal melanocytosis treated with combination therapy with nivolumab and ipilimumab.
    J Dermatol. 2022 Nov 28. doi: 10.1111/1346-8138.16658.
    PubMed    


  62. WATANABE T, Watanabe Y, Ikeda N, Aihara M, et al
    Serum levels of C-C motif chemokine ligand 2 and interleukin-8 as possible biomarkers in patients with toxic epidermal necrolysis accompanied by acute respiratory distress syndrome.
    J Dermatol. 2022 Nov 23. doi: 10.1111/1346-8138.16647.
    PubMed     Abstract available


  63. HASUI KI, Kawakami Y, Miyake T, Hirai Y, et al
    Cutaneous toxicity with suprabasal blisters and dyskeratosis following administration of enfortumab vedotin.
    J Dermatol. 2022 Nov 22. doi: 10.1111/1346-8138.16646.
    PubMed    


  64. WATANABE T, Watanabe Y, Asai C, Asami M, et al
    Risks of malignancies among patients with psoriasis: A cohort study of 360 patients.
    J Dermatol. 2022 Nov 22. doi: 10.1111/1346-8138.16644.
    PubMed     Abstract available


  65. SAEKI H, Akiyama M, Abe M, Igarashi A, et al
    English version of Japanese guidance for the use of oral Janus kinase (JAK) inhibitors in the treatments of atopic dermatitis.
    J Dermatol. 2022 Nov 22. doi: 10.1111/1346-8138.16635.
    PubMed     Abstract available


  66. NIE XJ, Hao BZ, Zhang BL, Li YY, et al
    GATA3 ameliorates melanocyte injuries in vitiligo through SIRT3-mediated HMGB1 deacetylation.
    J Dermatol. 2022 Nov 22. doi: 10.1111/1346-8138.16634.
    PubMed     Abstract available


  67. NAKAMURA K, Ashida A, Kiniwa Y, Okuyama R, et al
    Immune status and prognosis of stage II and III primary malignant melanoma: An analysis including 77 cases of acral lentiginous melanoma.
    J Dermatol. 2022 Nov 21. doi: 10.1111/1346-8138.16650.
    PubMed    


  68. NISHIMOTO A, Ansai SI, Akaishi S, Dohi T, et al
    Keloidal dermatofibroma: Clinicopathological comparison of 52 cases with a series of 2077 other dermatofibromas.
    J Dermatol. 2022 Nov 14. doi: 10.1111/1346-8138.16638.
    PubMed     Abstract available


  69. ZHANG J, Shu J, Sun H, Zhai T, et al
    CCN1 upregulates IL-36 via AKT/NF-kappaB and ERK/CEBP beta-mediated signaling pathways in psoriasis-like models.
    J Dermatol. 2022 Nov 14. doi: 10.1111/1346-8138.16611.
    PubMed     Abstract available


  70. MARUYAMA A, Katoh N
    Subacute cutaneous lupus erythematosus successfully treated with topical delgocitinib.
    J Dermatol. 2022 Nov 14. doi: 10.1111/1346-8138.16639.
    PubMed    


  71. MIZUTANI Y, Kanai Y, Murotani K, Honma M, et al
    Treatment with brodalumab is not associated with improved sleep problems in real-life patients with plaque psoriasis: Results of the ProLOGUE study.
    J Dermatol. 2022 Nov 7. doi: 10.1111/1346-8138.16620.
    PubMed     Abstract available


  72. LIU H, Wei R, Yang Y, Zhang Z, et al
    Successful treatment with secukinumab of psoriasis-like dermatitis in a patient with holocarboxylase synthetase deficiency.
    J Dermatol. 2022 Nov 7. doi: 10.1111/1346-8138.16625.
    PubMed     Abstract available


  73. JIANG T, Liu C
    Dissecting cellulitis of the scalp with typical clinical features: A retrospective cross-sectional study in a Department of Dermatology, Beijing, China.
    J Dermatol. 2022;49:1173-1177.
    PubMed     Abstract available


  74. NOBEYAMA Y, Umezawa Y, Asahina A
    Risk of squamous cell carcinoma in immunosuppressed patients with voriconazole-related actinic keratosis.
    J Dermatol. 2022;49:1168-1172.
    PubMed     Abstract available


  75. MIYAKE R, Iwamoto K, Sakai N, Matsunae K, et al
    Uptake of Staphylococcus aureus by keratinocytes is reduced by interferon-fibronectin pathway and filaggrin expression.
    J Dermatol. 2022;49:1148-1157.
    PubMed     Abstract available


  76. LI J, Tang JY, Fu J, Zhang MW, et al
    Carvedilol ameliorates persistent erythema of erythematotelangiectatic rosacea by regulating the status of anxiety/depression.
    J Dermatol. 2022;49:1139-1147.
    PubMed     Abstract available


  77. JIANG X, Wang Z, Lin Z, Xu Z, et al
    Incompletely penetrant TRPM4-associated progressive symmetric erythrokeratodermia responses to methotrexate.
    J Dermatol. 2022;49:e422-e423.
    PubMed    


  78. HONMA M, Sugawara M, Ueno N, Honma M, et al
    Clinical characteristics of peristomal pyoderma gangrenosum: A Single Center Retrospective Observational Study.
    J Dermatol. 2022;49:1178-1182.
    PubMed     Abstract available


  79. SASAOKA Y, Kotobuki Y, Fujimoto R, Tonomura K, et al
    A case of anti-RNA polymerase III antibody-positive systemic sclerosis with generalized morphea-like lesions correlated with elevation of peripheral eosinophil counts.
    J Dermatol. 2022;49:e417-e418.
    PubMed    


  80. KIDA A, Hayashi S, Ueno Y, Kitano H, et al
    Severe clinical manifestations in an extremely low birthweight preterm baby with vascular Ehlers-Danlos syndrome.
    J Dermatol. 2022;49:e411-e412.
    PubMed    


  81. CHEN H, Zhang G, Zhang P, Long H, et al
    Case of borderline leprosy presenting with urticaria-like eruptions and limbs swelling: A lesson to be learned for dermatologists.
    J Dermatol. 2022;49:e409-e410.
    PubMed    


  82. HIRAIWA T, Yamamoto T
    Nail lesions in palmoplantar pustulosis are not significantly associated with distal interphalangeal arthritis.
    J Dermatol. 2022;49:e403-e404.
    PubMed    


  83. LEE H, Song WJ, Koh SJ, Park H, et al
    Epidemiological association between alopecia areata and celiac disease: A meta-analysis.
    J Dermatol. 2022;49:e399-e400.
    PubMed    


  84. LIU Z, Cao X, Wan C
    Stupendous skin nodules: Necrobiotic xanthogranuloma with IgA-lambda and IgG-kappa monoclonal gammopathy.
    J Dermatol. 2022 Nov 1. doi: 10.1111/1346-8138.16622.
    PubMed    


    October 2022
  85. MORITA A, Tsai TF, Yee EYW, Okubo Y, et al
    Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled Effisayil 1 study.
    J Dermatol. 2022 Oct 25. doi: 10.1111/1346-8138.16609.
    PubMed     Abstract available


  86. KAMIYA K, Ohtsuki M
    Epidemiological survey of patients with psoriatic arthritis in the Japanese Society for Psoriasis Research from 2017 to 2020.
    J Dermatol. 2022 Oct 19. doi: 10.1111/1346-8138.16603.
    PubMed     Abstract available


  87. SHIMODA-KOMATSU Y, Mizukawa Y, Yamazaki Y, Ohyama M, et al
    Focal hypohidrosis in lesional skin in a probable case of confluent and reticulated papillomatosis: A case report with insight into the pathomechanism of recurrence.
    J Dermatol. 2022 Oct 19. doi: 10.1111/1346-8138.16616.
    PubMed     Abstract available


  88. MIYAJI Y, Yamamoto-Hanada K, Fukuie T, Narita M, et al
    Risk factors of admission in school children with severe atopic dermatitis.
    J Dermatol. 2022 Oct 18. doi: 10.1111/1346-8138.16612.
    PubMed     Abstract available


  89. YAHIRO C, Takai T, Nakatani S, Tanaka N, et al
    Skin rash associated with combined cytotoxic chemotherapy and immunotherapy for cancer: A retrospective single-center case series.
    J Dermatol. 2022 Oct 18. doi: 10.1111/1346-8138.16614.
    PubMed     Abstract available


  90. TAKANO-KAWASAKI S, Sato E, Yamaguchi K, Imafuku S, et al
    Trends in prescriptions of oral medications for psoriasis: A single-center retrospective study.
    J Dermatol. 2022 Oct 13. doi: 10.1111/1346-8138.16593.
    PubMed     Abstract available


  91. YUKI A, Takatsuka S, Abe R, Takenouchi T, et al
    Diagnostic accuracy of dermoscopy for 934 basal cell carcinomas: A single-center retrospective study.
    J Dermatol. 2022 Oct 13. doi: 10.1111/1346-8138.16607.
    PubMed     Abstract available


  92. SASAKI-SAITO N, Yamamura K, Hitaka T, Hirano Y, et al
    BRAF N581S and NRAS Q61R-mutated malignant melanoma and sensitivity to BRAF/MEK inhibitors.
    J Dermatol. 2022 Oct 11. doi: 10.1111/1346-8138.16592.
    PubMed    


  93. TAJIMA A, Yamazaki F, Huynh TNM, Ueda-Hayakawa I, et al
    A case of palisaded neutrophilic and granulomatous dermatitis associated with systemic lupus erythematosus presenting with pustules.
    J Dermatol. 2022 Oct 11. doi: 10.1111/1346-8138.16605.
    PubMed     Abstract available


  94. ISHIGURO A, Ogata D, Okuma K, Kashihara T, et al
    Malignant melanoma treatment using brachytherapy: Two case reports and 15 case series.
    J Dermatol. 2022 Oct 4. doi: 10.1111/1346-8138.16599.
    PubMed     Abstract available


  95. CHIU YJ, Weng HY, Lin YY, Lin YF, et al
    Genomic profiling with whole-exome sequencing revealed distinct mutations and novel pathways in Asian melanoma.
    J Dermatol. 2022 Oct 2. doi: 10.1111/1346-8138.16579.
    PubMed     Abstract available


  96. FAN W, Li Z, Wang Y, Zhang C, et al
    Imputation of the major histocompatibility complex region identifies major independent variants associated with bullous pemphigoid and dermatomyositis in Han Chinese.
    J Dermatol. 2022;49:998-1004.
    PubMed     Abstract available


  97. CAO Q, Zhang S, Wang J, Wang Y, et al
    Focal facial dermal dysplasias type III: Two families with Setleis syndrome in China.
    J Dermatol. 2022;49:1057-1061.
    PubMed     Abstract available


  98. BORGIA F, Li Pomi F, Alessandrello C, Vaccaro M, et al
    Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.
    J Dermatol. 2022;49:948-956.
    PubMed     Abstract available


  99. GONZALEZ-LOPEZ MA, Ocejo-Vinals JG, Lopez-Sundh AE, Guiral S, et al
    Biomarkers of endothelial dysfunction and atherosclerosis in hidradenitis suppurativa.
    J Dermatol. 2022;49:1052-1056.
    PubMed     Abstract available


  100. OHYAMA M, Matsudo K, Fujita T
    Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management.
    J Dermatol. 2022;49:939-947.
    PubMed     Abstract available


  101. KAMEDA E, Matsuzawa T, Togawa Y, Ikeda JI, et al
    Case of pigmented onychomatricoma: A relationship between dermoscopic and pathological findings.
    J Dermatol. 2022;49:e397-e398.
    PubMed    


  102. VERVERI A, Laidou S, Chatzidimitriou A, Gidaris D, et al
    Patient with recurrent mosaic KRAS variant: Rare oculoectodermal syndrome with severe neurologic phenotype.
    J Dermatol. 2022;49:e381-e382.
    PubMed    


  103. MIYAGAWA A, Adachi T, Arakawa H, Hamada M, et al
    A case of refractory leg ulcers caused by micro-arteriovenous fistula: Potential utility of ultrasonography in the diagnosis.
    J Dermatol. 2022;49:e389-e390.
    PubMed    


  104. MATSUKI Y, Uetake Y, Yamashita H, Yokoyama M, et al
    Case of a cellular blue nevus with multiple satellite lesions showing radial blue-white lesion: Unique dermoscopy-histopathology correlation in blue nevus with satellitosis.
    J Dermatol. 2022;49:e386-e388.
    PubMed    


    September 2022
  105. CHROMY D, Bartosik T, Brkic FF, Quint T, et al
    Dupilumab-induced skin-associated side effects in patients with chronic rhinosinusitis with nasal polyposis.
    J Dermatol. 2022 Sep 30. doi: 10.1111/1346-8138.16595.
    PubMed     Abstract available


  106. TOYODA T, Hashimoto K, Ogawa Y, Tohyama M, et al
    Immunohistological analysis of pathogenic infiltrates in the epidermis and liver of a patient with toxic epidermal necrolysis accompanied by vanishing bile duct syndrome.
    J Dermatol. 2022 Sep 29. doi: 10.1111/1346-8138.16576.
    PubMed     Abstract available


  107. KAMIYA K, Ohtsuki M
    Epidemiological survey of patients with pustular psoriasis in the Japanese Society for Psoriasis Research from 2017 to 2020.
    J Dermatol. 2022 Sep 24. doi: 10.1111/1346-8138.16583.
    PubMed     Abstract available


  108. MIYABE C, Oda T, Miyata R, Miyabe Y, et al
    Nephritis-associated plasmin receptor in the cutaneous vessels in IgA vasculitis.
    J Dermatol. 2022 Sep 24. doi: 10.1111/1346-8138.16574.
    PubMed    


  109. MORITA A, Yamaguchi Y, Tateishi C, Ikumi K, et al
    Efficacy and safety of apremilast and phototherapy versus phototherapy only in psoriasis vulgaris.
    J Dermatol. 2022 Sep 24. doi: 10.1111/1346-8138.16566.
    PubMed     Abstract available


  110. LEE ES, Kiuchi Y, Inomata N, Sueki H, et al
    Increased expression of human herpes virus 6 receptor CD134/OX40 in skin lesions of patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16575.
    PubMed     Abstract available


  111. TANAKA A, Niimi N, Takahashi M, Takahashi H, et al
    Prevalence of skin diseases and prognosis of atopic dermatitis in primary school children in populated areas of Japan from 2010 to 2019: The Asa Study in Hiroshima, Japan.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16577.
    PubMed     Abstract available


  112. WATANABE A, Kamata M, Shimizu T, Uchida H, et al
    Serum levels of angiogenesis-related factors in patients with psoriasis.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16588.
    PubMed     Abstract available


  113. HATTORI N, Koike Y, Murota H
    Skin microbiome analysis in a case of atopic dermatitis induced by an interleukin 17 inhibitor used to treat psoriasis.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16586.
    PubMed    


  114. FENG S, Song G, Liu L, Liu W, et al
    Allergen-specific immunotherapy induces monocyte-derived dendritic cells but attenuates their maturation and cytokine production in the lesional skin of an atopic dermatitis mouse model.
    J Dermatol. 2022 Sep 19. doi: 10.1111/1346-8138.16582.
    PubMed     Abstract available


  115. HIKI K, Ogata D, Hisada I, Sakamoto T, et al
    Minimally invasive surgery combined with excision and endoscopic submucosal dissection for anorectal melanoma.
    J Dermatol. 2022 Sep 16. doi: 10.1111/1346-8138.16581.
    PubMed    


  116. LU YY, Lu CC, Tsai CY, Liu YJ, et al
    Impact of seborrheic dermatitis on osteoporosis risk: A population-based cohort study.
    J Dermatol. 2022 Sep 12. doi: 10.1111/1346-8138.16578.
    PubMed     Abstract available


  117. MIYATA A, Kimura U, Hiruma M, Tanaka M, et al
    An atypical case of cutaneous candidiasis caused by a face mask: With useful dermoscopic findings.
    J Dermatol. 2022 Sep 12. doi: 10.1111/1346-8138.16573.
    PubMed    


  118. SHIBATA Y, Fukuda T, Nobeyama Y, Asahina A, et al
    Evaluation of nonalcoholic fatty liver disease in Japanese patients with psoriasis: Chest CT imaging for screening purposes.
    J Dermatol. 2022 Sep 8. doi: 10.1111/1346-8138.16564.
    PubMed     Abstract available


  119. MINAI L, Takeichi T, Ogawa Y, Honobe-Tabuchi A, et al
    Development of pemphigus vegetans and exacerbation of pemphigus foliaceus after secukinumab loading in a patient with complicated generalized pustular psoriasis and pyoderma gangrenosum.
    J Dermatol. 2022 Sep 2. doi: 10.1111/1346-8138.16563.
    PubMed     Abstract available


  120. HIRATA Y, Shiiya C, Miyamoto J, Saito M, et al
    Congenital curved nail of the fourth toe: Report of three cases and review of the literature.
    J Dermatol. 2022;49:925-927.
    PubMed     Abstract available


  121. LEEYAPHAN C, Nanchaipruek Y, Phinyo P
    Therapeutic outcomes and prognostic factors in patients with hypertrophic herpes simplex infection treated with imiquimod: A systematic review and meta-analysis of individual patient data from case reports and case series.
    J Dermatol. 2022;49:879-886.
    PubMed     Abstract available


  122. TORII H, Kishimoto M, Tanaka M, Noguchi H, et al
    Patient perceptions of psoriatic disease in Japan: Results from the Japanese subgroup of the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) survey.
    J Dermatol. 2022;49:818-828.
    PubMed     Abstract available


  123. JAWORSKA K, Slawinska M, Wyszomirski A, Lakomy J, et al
    Dermoscopic features of eyelid margin tumors: A single-center retrospective study.
    J Dermatol. 2022;49:851-861.
    PubMed     Abstract available


  124. HUANG L, Zhang J, Chen F, Zhang X, et al
    The first case of Chinese phacomatosis pigmentokeratotica diagnosed by a missense HRAS mosaicism.
    J Dermatol. 2022;49:921-924.
    PubMed     Abstract available


  125. CHAO YC, Hong JB, Liu C, Lee MS, et al
    COL7A1 G2287R mutation with two clinical phenotypes in the same family: Bullous dermolysis of the newborn and dystrophic epidermolysis bullosa pruriginosa.
    J Dermatol. 2022;49:e313-e314.
    PubMed    


  126. MIZUMAKI K, Makino S, Ikawa Y, Maeda S, et al
    Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-gamma antibody.
    J Dermatol. 2022;49:e311-e312.
    PubMed    


  127. TAKAMURA S, Teraki Y
    Treatment of bullous pemphigoid with dupilumab: Dupilumab exerts its effect by primarily suppressing T-helper 2 cytokines.
    J Dermatol. 2022;49:845-850.
    PubMed     Abstract available


    August 2022
  128. SUGAWARA-MIKAMI M, Kaneko H, Sasaki H, Sagawa N, et al
    Clinical features and antimicrobial treatment of skin infections caused by Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus.
    J Dermatol. 2022 Aug 26. doi: 10.1111/1346-8138.16548.
    PubMed     Abstract available


  129. XIAO Y, Gu Y, Xia D, Zhou X, et al
    Ixekizumab successfully treated refractory psoriasis concurrent bullous pemphigoid.
    J Dermatol. 2022 Aug 26. doi: 10.1111/1346-8138.16559.
    PubMed    


  130. SAEKI H, Ohya Y, Furuta J, Arakawa H, et al
    English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021.
    J Dermatol. 2022 Aug 22. doi: 10.1111/1346-8138.16527.
    PubMed     Abstract available


  131. HAGINO T, Saeki H, Kanda N
    The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan.
    J Dermatol. 2022 Aug 19. doi: 10.1111/1346-8138.16549.
    PubMed     Abstract available


  132. MIAO C, Chen Y, Wang Z, Xiang X, et al
    Real-world data on the use of secukinumab and acitretin in pediatric generalized pustular psoriasis.
    J Dermatol. 2022 Aug 18. doi: 10.1111/1346-8138.16551.
    PubMed     Abstract available


  133. SEGAWA Y, Tono H, Chiba H, Sato Y, et al
    Case series of modified dermis graft for skin defects of the nasal region.
    J Dermatol. 2022 Aug 12. doi: 10.1111/1346-8138.16544.
    PubMed     Abstract available


  134. MINAGAWA A, Uhara H, Ashida A, Koga H, et al
    Clinical history analysis of Japanese melanoma cases and characteristics of melanoma with childhood onset.
    J Dermatol. 2022 Aug 10. doi: 10.1111/1346-8138.16545.
    PubMed     Abstract available


  135. TADA Y, Kim H, Spanopoulos D, Habiro K, et al
    Treatment patterns, healthcare resource utilization, and costs in patients with moderate-to-severe psoriasis treated with systemic therapy in Japan: A retrospective claims database study.
    J Dermatol. 2022 Aug 10. doi: 10.1111/1346-8138.16543.
    PubMed     Abstract available


  136. TANAKA A, Miyauchi T, Kitamura S, Iwata H, et al
    Carotenoderma due to lycopenemia: A case report and evaluation of lycopene deposition in the skin.
    J Dermatol. 2022 Aug 8. doi: 10.1111/1346-8138.16537.
    PubMed     Abstract available


  137. KIM M, Kim M, Kim JW, Kim BR, et al
    Clinical characteristics of pustulotic arthro-osteitis in Korea.
    J Dermatol. 2022;49:762-768.
    PubMed     Abstract available


  138. LIN YC, Tu WT, Hou PC, Huang HY, et al
    Autosomal dominant epidermolysis bullosa simplex exacerbated by hyperkeratotic scabies.
    J Dermatol. 2022;49:e283-e284.
    PubMed    


  139. CHEN CL, Wu CY, Lyu YS, Chou YJ, et al
    Association between bullous pemphigoid and risk of venous thromboembolism: A nationwide population-based cohort study.
    J Dermatol. 2022;49:753-761.
    PubMed     Abstract available


  140. HSU TC, Yu PH, Chang YH, Guevara BEK, et al
    Novel compound heterozygous indel ZMPSTE24 mutations in a Taiwanese male infant with restrictive dermopathy.
    J Dermatol. 2022;49:e280-e282.
    PubMed    


  141. SHIRAHAMA T, Hamada T, Abe T, Arakawa M, et al
    Dermoscopic furrow ink test of the palmar lesion in loricrin keratoderma.
    J Dermatol. 2022;49:783-786.
    PubMed     Abstract available


  142. MATSUOKA A, Fujii K, Kanekura T
    Clear cell syringoma: Disappearance of clear cells after improvement in diabetes mellitus by pituitary adenoma resection.
    J Dermatol. 2022;49:e268-e269.
    PubMed    


  143. MITSUISHI T, Miyata K, Ando A, Sano K, et al
    Author reply to "Onycholysis associated with Kawasaki disease: A comment on characteristic nail lesions in Kawasaki disease: Case series and literature review".
    J Dermatol. 2022;49:e293-e294.
    PubMed    


  144. MIYAZAKI A, Takeichi T, Takeuchi S, Taki T, et al
    Extremely mild dominant dystrophic epidermolysis bullosa: Genotype information from whole-exome sequencing of salivary gDNA predicts disease severity.
    J Dermatol. 2022;49:e276-e277.
    PubMed    


  145. TANAKA A, Yanagi T, Seo T, Mai S, et al
    Ecthyma gangrenosum caused by Streptococcus pyogenes: Report of a case and review of the literature.
    J Dermatol. 2022;49:e266-e267.
    PubMed    


  146. MIYAZAKI A, Taki T, Takeichi T, Kono M, et al
    Darier disease successfully treated with a topical agent containing vitamin A (retinyl palmitate), vitamin E, and urea.
    J Dermatol. 2022;49:779-782.
    PubMed     Abstract available


  147. KAMEDA E, Togawa Y, Maru Y, Matsue H, et al
    Ungual seborrheic keratosis with longitudinal melanonychia: A case report.
    J Dermatol. 2022;49:775-778.
    PubMed     Abstract available


  148. YAMASHITA A, Fukui T, Akasaka E, Nakajima K, et al
    A mild case of acute generalized exanthematous pustulosis caused by gemcitabine.
    J Dermatol. 2022;49:e261-e263.
    PubMed    


  149. HIRANO Y, Kitamura S, Seo T, Yoshimoto N, et al
    Multiple actinic keratosis on the face associated with pirfenidone-induced photosensitivity.
    J Dermatol. 2022;49:e253-e254.
    PubMed    


  150. OTANI A, Iio K, Hataya H
    Onycholysis associated with Kawasaki disease: A comment on "Characteristic nail lesions in Kawasaki disease: Case series and literature review".
    J Dermatol. 2022;49:e291-e292.
    PubMed    


    July 2022
  151. MELSON GJ, Hong SG, Brem CE
    Melanocytic matricoma with atypical features: A case of malignant melanocytic matricoma?
    J Dermatol. 2022 Jul 30. doi: 10.1111/1346-8138.16536.
    PubMed     Abstract available


  152. FUJISHIMA C, Tahara J, Munemoto S, Hioki C, et al
    Cutaneous nontuberculous mycobacterial infections in Japan: Review of the Japanese literature.
    J Dermatol. 2022 Jul 29. doi: 10.1111/1346-8138.16531.
    PubMed     Abstract available


  153. SHEN M, Xiao H, Zhu W, Lu Y, et al
    Comparing willingness-to-pay and time-trade-off as the measures of burden of psoriasis: A pooled analysis of community, hospital, and web-based samples in China.
    J Dermatol. 2022 Jul 29. doi: 10.1111/1346-8138.16522.
    PubMed     Abstract available


  154. FUKADA N, Suzuki T, Aoyama K, Kinjo A, et al
    Bullous pemphigoid during the treatment of psoriasis vulgaris with risankizumab.
    J Dermatol. 2022 Jul 29. doi: 10.1111/1346-8138.16534.
    PubMed    


  155. YAMAZAKI N, Shimizu A, Ozaki M, Hamada M, et al
    Real-world safety and effectiveness of pembrolizumab in Japanese patients with radically unresectable melanoma: An all-case postmarketing surveillance in Japan.
    J Dermatol. 2022 Jul 27. doi: 10.1111/1346-8138.16518.
    PubMed     Abstract available


  156. MAAS EJ, Wallingford CK, McGuire JJ, Rutjes C, et al
    Amelanotic/hypopigmented melanoma in a sibship with oculocutaneous albinism.
    J Dermatol. 2022 Jul 27. doi: 10.1111/1346-8138.16528.
    PubMed     Abstract available


  157. MATSUOKA A, Fujii K, Higashi Y, Yoshimitsu M, et al
    Subcutaneous panniculitis-like T-cell lymphoma associated with methotrexate treatment.
    J Dermatol. 2022 Jul 26. doi: 10.1111/1346-8138.16524.
    PubMed    


  158. HAYAMA K, Fujita H, Terui T
    Current trend in the treatment of generalized pustular psoriasis in Japan: Results from a questionnaire-based epidemiological study.
    J Dermatol. 2022 Jul 25. doi: 10.1111/1346-8138.16530.
    PubMed    


  159. KAWAKAMI T, Nakade I, Tamura Y, Ito F, et al
    Typical cutaneous small-vessel vasculitis induced by combined injection of antiphosphatidylserine/prothrombin complex antibody and anti-LAMP-2 antibody in normal rats.
    J Dermatol. 2022 Jul 25. doi: 10.1111/1346-8138.16523.
    PubMed     Abstract available


  160. SAKAMOTO K, Baba T, Mori H, Misawa J, et al
    T cell-rich perivascular inflammation in a case of cutaneous variant intravascular large B-cell lymphoma.
    J Dermatol. 2022 Jul 25. doi: 10.1111/1346-8138.16529.
    PubMed    


  161. SAEKI H, Kanai Y, Murotani K, Ito K, et al
    Work productivity in real-life employed patients with plaque psoriasis: Results from the ProLOGUE study.
    J Dermatol. 2022 Jul 20. doi: 10.1111/1346-8138.16517.
    PubMed     Abstract available


  162. JO SJ, Park CJ, Bang CH, Jeong KH, et al
    Calcipotriol/betamethasone aerosol foam (Enstilum) for the topical treatment of psoriasis vulgaris in routine practice in Korea: A prospective, noninterventional, multicenter study of treatment outcomes and patient satisfaction.
    J Dermatol. 2022 Jul 18. doi: 10.1111/1346-8138.16519.
    PubMed     Abstract available


  163. KISHIBE M, Takeda K, Honma M, Makino Y, et al
    Effectiveness of anti-interleukin-17-receptor antibody for hydroxychloroquine-induced generalized pustular psoriasis in a patient with systemic lupus erythematosus.
    J Dermatol. 2022 Jul 15. doi: 10.1111/1346-8138.16514.
    PubMed    


  164. KOGA H, Tsutsumi M, Teye K, Ishii N, et al
    Subcorneal pustular dermatosis-type IgA pemphigus associated with multiple myeloma: A case report and literature review.
    J Dermatol. 2022 Jul 15. doi: 10.1111/1346-8138.16516.
    PubMed     Abstract available


  165. MIZUNO Y, Shibata S, Miyagaki T, Ito Y, et al
    Serum cell-free DNA as a new biomarker in cutaneous T-cell lymphoma.
    J Dermatol. 2022 Jul 12. doi: 10.1111/1346-8138.16520.
    PubMed     Abstract available


  166. IMAI H, Hashimoto S, Ninomiya R, Luo J, et al
    Pharmacokinetics of lanoconazole in human skin after repeated topical application.
    J Dermatol. 2022 Jul 10. doi: 10.1111/1346-8138.16515.
    PubMed     Abstract available


  167. TACHIBANA K, Ohkawa Y, Kanto N, Maeda K, et al
    The expression of keratan sulfate in malignant melanoma enhances the adhesion and invasion activity of melanoma cells.
    J Dermatol. 2022 Jul 10. doi: 10.1111/1346-8138.16506.
    PubMed     Abstract available


  168. MORITA A, Nishikawa K, Yamada F, Yamanaka K, et al
    Safety, efficacy, and drug survival of the infliximab biosimilar CT-P13 in post-marketing surveillance of Japanese patients with psoriasis.
    J Dermatol. 2022 Jul 7. doi: 10.1111/1346-8138.16508.
    PubMed     Abstract available


  169. TSUNODA K, Watabe D, Amano H
    Exacerbation of psoriasis following vaccination with the Pfizer-BioNTech BTN162b2 mRNA COVID-19 vaccine during risankizumab treatment.
    J Dermatol. 2022 Jul 7. doi: 10.1111/1346-8138.16505.
    PubMed    


  170. MARTIN A, Gouveia BM, Rawson R, Guitera P, et al
    Complex management of lentigo maligna in the setting of chrysiasis, argyriasis, and tattoo using in vivo reflectance confocal microscopy.
    J Dermatol. 2022;49:703-709.
    PubMed     Abstract available


  171. SUGIYAMA S, Yamamoto T, Aoyama Y
    Clinical features of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid in Japan: A nationwide retrospective observational study.
    J Dermatol. 2022;49:697-702.
    PubMed     Abstract available


  172. IKEDA T, Yokoyama K, Kawakami T
    Heliotrope-like manifestation of adult-onset Still disease with macrophage activation syndrome: A case-based review.
    J Dermatol. 2022;49:736-740.
    PubMed     Abstract available


  173. KAWAKAMI T, Yokoyama K, Ikeda T, Nishibata Y, et al
    Presence of neutrophil extracellular traps in superficial venous thrombosis of Behcet's disease.
    J Dermatol. 2022;49:741-745.
    PubMed     Abstract available


  174. MOCHIZUKI T, Yamada S, Hironaga M, Futatsuya T, et al
    Change in dominant genotype of Microsporum canis, a causative fungus of zoonotic dermatophytosis, in Japan over the past 40 years.
    J Dermatol. 2022;49:682-690.
    PubMed     Abstract available


  175. IWANAGA A, Murota H
    Author reply to comment on "Clinical practice guidelines for pseudoxanthoma elasticum (2017)": The importance of mutation analysis.
    J Dermatol. 2022;49:e250.
    PubMed    


  176. ANDO Y, Ohshima Y, Yanagishita T, Watanabe H, et al
    Clinical utility of botulinum toxin type A local injection therapy for head and forehead hyperhidrosis.
    J Dermatol. 2022;49:719-723.
    PubMed     Abstract available


  177. KITAO R, Oda Y, Washio K, Tai Y, et al
    Lower efficacy of omalizumab in older adults with chronic spontaneous urticaria.
    J Dermatol. 2022;49:729-731.
    PubMed     Abstract available


  178. LI Q, Terry SF, Uitto J
    Comment on "Clinical practice guidelines for pseudoxanthoma elasticum (2017)": The importance of mutation analysis.
    J Dermatol. 2022;49:e248-e249.
    PubMed    


  179. XU M, Yan J
    2940-nm multifractional erbium:yttrium-aluminum-garnet laser for the treatment of dissecting cellulitis of the scalp: Case reports and literature review.
    J Dermatol. 2022;49:e230-e231.
    PubMed    


  180. KAWAMURA T, Mai Y, Narahira A, Matsuno Y, et al
    Regression of acquired reactive perforating collagenosis after dipeptidyl peptidase-4 inhibitor cessation.
    J Dermatol. 2022;49:e238-e240.
    PubMed    


  181. HAYASHI M, Wataya-Kaneda M, Koguchi-Yoshioka H, Arase N, et al
    Familial Michelin tire baby syndrome.
    J Dermatol. 2022;49:e219-e220.
    PubMed    


  182. IINUMA S, Hayashi K, Tsuda T, Nakano S, et al
    Hidradenitis suppurativa associated with immunoglobulin A-dominant infection-related glomerulonephritis.
    J Dermatol. 2022;49:e224-e225.
    PubMed    


  183. CHULAROJANAMONTRI L, Tuchinda P, Rujitharanawong C, Hunnangkul S, et al
    New-onset and exacerbated skin diseases after COVID-19 infection: A systematic review.
    J Dermatol. 2022 Jul 1. doi: 10.1111/1346-8138.16501.
    PubMed    


    June 2022
  184. JIAO J, Zhao X, Wang Y, Liang N, et al
    Normal mesenchymal stem cells can improve the abnormal function of T cells in psoriasis via upregulating transforming growth factor-beta receptor.
    J Dermatol. 2022 Jun 29. doi: 10.1111/1346-8138.16490.
    PubMed     Abstract available


  185. UMEDA Y, Teramoto Y, Asami Y, Matsuya T, et al
    Comparison of surgical morbidities between LigaSure and conventional techniques in inguinal or ilioinguinal lymph node dissection for skin cancer: A single center retrospective study.
    J Dermatol. 2022 Jun 27. doi: 10.1111/1346-8138.16502.
    PubMed     Abstract available


  186. HORII M, Fushida N, Ikeda T, Oishi K, et al
    Cytokine-producing B-cell balance associates with skin fibrosis in patients with systemic sclerosis.
    J Dermatol. 2022 Jun 25. doi: 10.1111/1346-8138.16495.
    PubMed     Abstract available


  187. LIM SH, Koh SB, Lee WS, Lee S, et al
    Rapidly increasing incidence and prevalence of lichen planopilaris in an Asian population: A Korean nationwide population-based study.
    J Dermatol. 2022 Jun 21. doi: 10.1111/1346-8138.16498.
    PubMed    


  188. PRUESSMANN JN, Langan EA, Rupp J, Marquardt J, et al
    Challenge of hepatitis B testing following intravenous immunoglobulin therapy in patients with autoimmune skin diseases.
    J Dermatol. 2022 Jun 21. doi: 10.1111/1346-8138.16500.
    PubMed     Abstract available


  189. QIN H, Lu J, Yi X, Ding Y, et al
    Secukinumab treatment for a psoriasis patient co-infected with HIV and latent tuberculosis: A case report.
    J Dermatol. 2022 Jun 21. doi: 10.1111/1346-8138.16494.
    PubMed    


  190. MITSUI Y, Shobatake C, Ogawa K, Hirai T, et al
    Usefulness of ultrasonography in the preoperative diagnosis of mixed tumor of the skin (chondroid syringoma): A case series with nine patients.
    J Dermatol. 2022 Jun 19. doi: 10.1111/1346-8138.16497.
    PubMed    


  191. CHI MH, Chung WH, Hui RC, Chen CB, et al
    Clinical features and outcomes in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    J Dermatol. 2022 Jun 17. doi: 10.1111/1346-8138.16476.
    PubMed     Abstract available


  192. TANAKA M, Miyagaki T, Sato N, Akita T, et al
    Epidermotropic cutaneous T-cell lymphoma with follicular helper T-cell phenotype limited to one anatomical region.
    J Dermatol. 2022 Jun 17. doi: 10.1111/1346-8138.16492.
    PubMed    


  193. KATOH N, Saeki H, Kataoka Y, Etoh T, et al
    Evaluation of standard treatments for managing adult Japanese patients with inadequately controlled moderate-to-severe atopic dermatitis: Two-year data from the ADDRESS-J disease registry.
    J Dermatol. 2022 Jun 17. doi: 10.1111/1346-8138.16485.
    PubMed     Abstract available


  194. NOMOTO Y, Fujii K, Nakamura D, Gushi A, et al
    Epstein-Barr virus-positive primary cutaneous Hodgkin lymphoma.
    J Dermatol. 2022 Jun 16. doi: 10.1111/1346-8138.16489.
    PubMed    


  195. CHIANG CP, Hung CT, Chen YH, Chen CY, et al
    Stevens-Johnson syndrome and toxic epidermal necrolysis associated with increased risk of developing psychiatric disorders: A retrospective population-based cohort study in Taiwan.
    J Dermatol. 2022 Jun 10. doi: 10.1111/1346-8138.16487.
    PubMed     Abstract available


  196. SAITO S, Tanaka R, Ono N, Umegaki-Arao N, et al
    Palmar whitish change after water exposure in a familial mild case of loricrin keratoderma (loricrin ichthyosis).
    J Dermatol. 2022 Jun 3. doi: 10.1111/1346-8138.16481.
    PubMed    


  197. FUJIMOTO T, Okatsu H, Miyama H
    Two-week prospective observational study of 5% sofpironium bromide gel in Japanese patients with primary axillary hyperhidrosis.
    J Dermatol. 2022;49:594-599.
    PubMed     Abstract available


  198. YANG L, Zhou N, Alamgir M, Wang Z, et al
    Risk factors of long-term alopecia after pulsed-dye laser treatment for infantile scalp hemangiomas: A retrospective study.
    J Dermatol. 2022;49:661-665.
    PubMed     Abstract available


  199. EDSON-HEREDIA E, Aranishi T, Isaka Y, Anderson P, et al
    Patient and physician perspectives on alopecia areata: A real-world assessment of severity and burden in Japan.
    J Dermatol. 2022;49:575-583.
    PubMed     Abstract available


  200. ITO T, Kamei K, Yuasa A, Matsumoto F, et al
    Health-related quality of life in patients with alopecia areata: Results of a Japanese survey with norm-based comparisons.
    J Dermatol. 2022;49:584-593.
    PubMed     Abstract available


  201. YANAGIDA N, Takahagi S, Aoyama Y, Tanaka A, et al
    Anhidrosis accompanied by cholinergic urticaria-like rash and dermal pain in a patient with Sjogren's syndrome.
    J Dermatol. 2022;49:666-670.
    PubMed     Abstract available


  202. MIYAZAKI S, Nakano H, Mizuno M, Ozaki S, et al
    Two novel mutations in the ATP2C1 gene found in Japanese patients with Hailey-Hailey disease.
    J Dermatol. 2022;49:656-660.
    PubMed     Abstract available


  203. SUZUKI H, Namiki T, Enzan N, Tanaka A, et al
    Novel mutation in the UROS gene causing congenital erythropoietic porphyria in an elderly Japanese female.
    J Dermatol. 2022;49:e215-e216.
    PubMed    


  204. HOSOMI S, Fujimoto K, Fujiwara Y
    Curly hair caused by selenium deficiency in an adult woman.
    J Dermatol. 2022;49:e197-e198.
    PubMed    


    May 2022
  205. WANG WY, Yu S, Hu SC
    Subacute cutaneous lupus erythematosus following ChAdOx1 nCoV-19 vaccination.
    J Dermatol. 2022 May 27. doi: 10.1111/1346-8138.16473.
    PubMed    


  206. KOO T, Baek G, Jue MS
    Risk of tuberculosis infection and serial changes in interferon-gamma release assays in elderly patients with psoriasis receiving biologic therapy.
    J Dermatol. 2022 May 26. doi: 10.1111/1346-8138.16471.
    PubMed     Abstract available


  207. SALAVA A, Salo V, Remitz A
    Keratosis pilaris and filaggrin loss-of-function mutations in patients with atopic dermatitis - Results of a Finnish cross-sectional study.
    J Dermatol. 2022 May 26. doi: 10.1111/1346-8138.16477.
    PubMed     Abstract available


  208. UHARA H, Tsuchida T, Kiyohara Y, Akamatsu A, et al
    Safety and effectiveness of nivolumab in Japanese patients with malignant melanoma: Final analysis of a post-marketing surveillance.
    J Dermatol. 2022 May 23. doi: 10.1111/1346-8138.16432.
    PubMed     Abstract available


  209. CANU D, Doutre MS
    Regression of sarcoidosis skin lesions after receiving the Moderna anti-coronavirus disease 2019 vaccine.
    J Dermatol. 2022 May 19. doi: 10.1111/1346-8138.16438.
    PubMed    


  210. YOSHIOKA A, Kunisada M, Fukuda H, Kubo A, et al
    Autoimmune progesterone dermatitis treated with dienogest: A case report.
    J Dermatol. 2022 May 19. doi: 10.1111/1346-8138.16445.
    PubMed    


  211. ARAKAWA N, Watabe D, Tanji T, Amano H, et al
    Childhood granulomatous periorificial dermatitis showing a good response to doxycycline.
    J Dermatol. 2022 May 17. doi: 10.1111/1346-8138.16437.
    PubMed    


  212. GOTO H, Kondo M, Iida S, Matsushima Y, et al
    Psoriasis-like skin lesions occurring at remote sites after topical imiquimod.
    J Dermatol. 2022 May 15. doi: 10.1111/1346-8138.16443.
    PubMed    


  213. MORITZ S, Penney D, Weidinger S, Gabbert T, et al
    A randomized controlled trial on a novel behavioral treatment for individuals with skin picking and other body-focused repetitive behaviors.
    J Dermatol. 2022 May 15. doi: 10.1111/1346-8138.16435.
    PubMed    


  214. GRACA A, Martins AM, Ribeiro HM, Marques Marto J, et al
    Indirect consequences of coronavirus disease 2019: Skin lesions caused by the frequent hand sanitation and use of personal protective equipment and strategies for their prevention.
    J Dermatol. 2022 May 13. doi: 10.1111/1346-8138.16431.
    PubMed     Abstract available


  215. TACHIBANA K, Kawakami Y, Tokuda M, Sato S, et al
    Flare-up of generalized pustular psoriasis following Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine: Two cases without mutations of IL36RN and CARD14 genes.
    J Dermatol. 2022 May 13. doi: 10.1111/1346-8138.16442.
    PubMed    


  216. KITAJIMA Y, Yamashina M, Hanamoto M, Shijimaya T, et al
    Primary cutaneous anaplastic large cell lymphoma with DUSP22-IRF4 rearrangement demonstrating a biphasic histopathologic pattern and a complete natural regression.
    J Dermatol. 2022 May 13. doi: 10.1111/1346-8138.16424.
    PubMed    


  217. KASE M, Fujita Y, Ota A, Shimizu S, et al
    Loss of epidermal Langerhans cells in psoriasiform lesions of de novo induced or worsened pre-existing psoriasis following uses of immune checkpoint inhibitors.
    J Dermatol. 2022 May 12. doi: 10.1111/1346-8138.16427.
    PubMed     Abstract available


  218. NOMOTO Y, Higashi Y, Uchida Y, Fujii K, et al
    Disseminated cutaneous sporotrichosis with intravascular granuloma.
    J Dermatol. 2022 May 10. doi: 10.1111/1346-8138.16429.
    PubMed    


  219. TAMAI M, Sakamoto R, Goto N, Morimura O, et al
    Cutaneous manifestations of coronavirus disease 2019 patients in Japan.
    J Dermatol. 2022 May 10. doi: 10.1111/1346-8138.16433.
    PubMed     Abstract available


  220. SASAKI R, Asano Y, Fujimura T
    A pediatric case of corticosteroid-resistant erosive pustular dermatosis of scalp-like alopecia treated successfully with oral indomethacin, doxycycline, and topical tacrolimus.
    J Dermatol. 2022 May 10. doi: 10.1111/1346-8138.16425.
    PubMed    


  221. KAMIMURA A, Nakamura Y, Takenouchi T, Matsushita S, et al
    Concordance in judgment of clinical borders of basal cell carcinomas in Japanese patients: A preliminary study of JCOG2005 (J-BASE-MARGIN).
    J Dermatol. 2022 May 5. doi: 10.1111/1346-8138.16422.
    PubMed     Abstract available


  222. JUNG JM, Yang HJ, Lee WJ, Won CH, et al
    Association between psoriasis and alopecia areata: A systematic review and meta-analysis.
    J Dermatol. 2022 May 5. doi: 10.1111/1346-8138.16420.
    PubMed     Abstract available


  223. MATSUDATE Y
    Case of allergic contact dermatitis due to nickel contained in stainless steel skull pins.
    J Dermatol. 2022 May 3. doi: 10.1111/1346-8138.16421.
    PubMed    


  224. SAWAMURA S, Kajihara I, Sakamoto R, Otsuka-Maeda S, et al
    Elevation of circulating interleukin-23 DNA levels in patients with psoriasis.
    J Dermatol. 2022 May 2. doi: 10.1111/1346-8138.16418.
    PubMed    


  225. WANG L, Xing H
    Primary localized cutaneous amyloidosis presenting only as hypopigmented patches: A case report.
    J Dermatol. 2022 May 2. doi: 10.1111/1346-8138.16378.
    PubMed    


  226. OHN J, Choi YG, Yun J, Jo SJ, et al
    Identifying patients with deteriorating generalized pustular psoriasis: Development of a prediction model.
    J Dermatol. 2022 May 2. doi: 10.1111/1346-8138.16383.
    PubMed     Abstract available


  227. TAKAMIYAGI S, Iriki H, Asahina Y, Furuichi Y, et al
    Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    J Dermatol. 2022 May 2. doi: 10.1111/1346-8138.16415.
    PubMed     Abstract available


  228. YAMASAKI K, Yamanaka K, Zhao Y, Iwano S, et al
    Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Final analysis of a 52-week phase 3 open-label study.
    J Dermatol. 2022;49:479-487.
    PubMed     Abstract available


  229. LIU T, Li J, Deng Z, Chen M, et al
    Increased serum levels of CCL3, CXCL8, CXCL9, and CXCL10 in rosacea patients and their correlation with disease severity.
    J Dermatol. 2022;49:525-533.
    PubMed     Abstract available


  230. XIAO T, Liu Y, Wang T, Ren J, et al
    Two novel mutations of SERPINB7 in eight cases of Nagashima-type palmoplantar keratosis in the Chinese population.
    J Dermatol. 2022;49:539-544.
    PubMed     Abstract available


  231. WADA-IRIMADA M, Yamamoto H, Terui H, Omori-Shimada R, et al
    Characterization of rosacea patients in Tohoku area of Japan: Retrospective study of 340 rosacea cases.
    J Dermatol. 2022;49:519-524.
    PubMed     Abstract available


  232. MATSUBARA A, Tsuchida N, Sakurai M, Maeda A, et al
    A case of VEXAS syndrome with Sweet's disease and pulmonary involvement.
    J Dermatol. 2022;49:e177-e178.
    PubMed    


  233. MUNEMOTO S, Tsuchihara K, Fujishima C, Hioki C, et al
    Novel mutation of the ferrochelatase gene in a Japanese boy with erythropoietic protoporphyria.
    J Dermatol. 2022;49:e179-e180.
    PubMed    


  234. HOSHINA D, Orita A
    Sweet syndrome after severe acute respiratory syndrome coronavirus 2 mRNA vaccine: A case report and literature review.
    J Dermatol. 2022;49:e175-e176.
    PubMed    


  235. HSU CH, Tu WT, Chen PC, Yu-Yun Lee J, et al
    Novel compound heterozygous ITGB4 mutations underlie lethal junctional epidermolysis bullosa with pyloric atresia and aplasia cutis congenita.
    J Dermatol. 2022;49:e154-e156.
    PubMed    


  236. SASAKI H, Fujishima C, Hioki C, Yoshida H, et al
    A case of paraneoplastic pemphigus associated with other iatrogenic immunodeficiency-associated lymphoproliferative disorders.
    J Dermatol. 2022;49:e165-e166.
    PubMed    


  237. WADA S, Namiki T, Miura K
    Mononuclear variant of adult xanthogranuloma associated with B-cell acute lymphocytic leukemia.
    J Dermatol. 2022;49:e161-e162.
    PubMed    


  238. TANAKA A, Kitamura S, Yanagi T, Seo T, et al
    Case of penile Bowen's disease on postoperative lymphedema associated with human papilloma virus type 52.
    J Dermatol. 2022;49:e163-e164.
    PubMed    


  239. KITAYAMA S, Makino T, Mizawa M, Shimizu T, et al
    Newborn twins with neonatal pemphigoid gestationis.
    J Dermatol. 2022;49:e157-e158.
    PubMed    


    April 2022
  240. OTA M, Nobeyama Y, Asahina A
    Case of hypothyroidism-diagnostic unclassified cutaneous mucinosis showing a plaque on the flank region.
    J Dermatol. 2022 Apr 28. doi: 10.1111/1346-8138.16414.
    PubMed    


  241. WAKI Y, Nobeyama Y, Katsumata F, Asahina A, et al
    Successful treatment with dacarbazine against a parathyroid hormone-related protein-producing melanoma causing hypercalcemia after immune checkpoint inhibitor failure.
    J Dermatol. 2022 Apr 27. doi: 10.1111/1346-8138.16411.
    PubMed     Abstract available


  242. BOMZE D, Sprecher E, Geller S
    Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysis.
    J Dermatol. 2022 Apr 27. doi: 10.1111/1346-8138.16398.
    PubMed     Abstract available


  243. YU R, Chen S, Pan Y, Ma C, et al
    Combined use of cyclosporine in the treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis.
    J Dermatol. 2022 Apr 19. doi: 10.1111/1346-8138.16369.
    PubMed     Abstract available


  244. SHU J, Yamamoto Y, Aoyama K, Togawa Y, et al
    Assessment of malignant melanoma lesions using violet-light dermoscopy: A case report.
    J Dermatol. 2022 Apr 17. doi: 10.1111/1346-8138.16389.
    PubMed     Abstract available


  245. YAMANAKA K, Sato K, Masaki T, Nakano E, et al
    Basal cell carcinoma derived from epidermal cyst of the knee of a patient with xeroderma pigmentosum group C.
    J Dermatol. 2022 Apr 12. doi: 10.1111/1346-8138.16375.
    PubMed    


  246. CHAROENPIPATSIN N, Chularojanamontri L, Rujitharanawong C, Tuchinda P, et al
    Rituximab-induced psoriasis in a patient with pemphigus foliaceous: A case report and literature review.
    J Dermatol. 2022 Apr 5. doi: 10.1111/1346-8138.16367.
    PubMed    


  247. WATANABE H, Ashida M, Satomi N, Koike Y, et al
    Histopathological analysis of skin reactions after coronavirus disease 2019 vaccination: Increment in number of infiltrated plasmacytoid dendritic cell.
    J Dermatol. 2022 Apr 4. doi: 10.1111/1346-8138.16374.
    PubMed     Abstract available


  248. OKA Y, Fukumoto T, Imamura S, Horita N, et al
    Atypical Gianotti-Crosti syndrome like skin lesions following vaccination.
    J Dermatol. 2022 Apr 4. doi: 10.1111/1346-8138.16385.
    PubMed    


  249. NAKAJIMA K, Suzuki H, Yamamoto M, Yamamoto T, et al
    A familial case of periodontal Ehlers-Danlos syndrome lacking skin extensibility and joint hypermobility with a missense mutation in C1R.
    J Dermatol. 2022 Apr 1. doi: 10.1111/1346-8138.16372.
    PubMed     Abstract available


  250. KURIHARA K, Fujiyama T, Tokura Y, Honda T, et al
    Possible involvement of interleukin-22-producing CD103(+) CD8(+) T cells in the epidermal hyperplasia of atopic dermatitis.
    J Dermatol. 2022 Apr 1. doi: 10.1111/1346-8138.16382.
    PubMed    


  251. HAYASHI N, Hayama K, Takahashi K, Kurokawa I, et al
    Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12-week interim analysis of post-marketing surveillance in Japan.
    J Dermatol. 2022;49:411-421.
    PubMed     Abstract available


  252. WANG Y, Wang J, Li Y, Pan C, et al
    AQP5 pathogenic variants induce palmoplantar keratoderma Bothnia type in two Chinese families.
    J Dermatol. 2022;49:463-468.
    PubMed     Abstract available


  253. CORDERO-RAMOS J, Barros-Tornay R, Toledo-Pastrana T, Ferrandiz L, et al
    Effectiveness and safety of topical 15% resorcinol in the management of mild-to-moderate hidradenitis suppurativa: A cohort study.
    J Dermatol. 2022;49:459-462.
    PubMed     Abstract available


  254. NAKAI Y, Ashida H, Kajita A, Yokoyama E, et al
    Impetigo herpetiformis successfully treated with brodalumab.
    J Dermatol. 2022;49:e149-e150.
    PubMed    


  255. ZHOU X, Cheng L, Wang Y, Gou H, et al
    Effect of NUDT15 polymorphisms on early hematological safety of low-dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study.
    J Dermatol. 2022;49:402-410.
    PubMed     Abstract available


  256. KOREKAWA A, Nakajima K, Nakano H, Sawamura D, et al
    Clarithromycin for the treatment of pyoderma gangrenosum associated with myelodysplastic syndrome.
    J Dermatol. 2022;49:e131-e132.
    PubMed    


  257. MIZAWA M, Makino T, Furukawa F, Torai R, et al
    Efficacy of Q-switched ruby laser treatment for pigmented fungiform papillae of the tongue.
    J Dermatol. 2022;49:e133-e134.
    PubMed    


  258. HATORI Y, Kawakita H, Ito M, Kobayashi K, et al
    Subungual arteriovenous hemangioma mimicking subungual malignant tumor.
    J Dermatol. 2022;49:e127-e128.
    PubMed    


    March 2022
  259. TAKEI S, Hashimoto W, Tasaki K, Hashimoto T, et al
    Cutaneous infection caused by the Scedosporium apiospermum complex.
    J Dermatol. 2022 Mar 30. doi: 10.1111/1346-8138.16381.
    PubMed    


  260. SASAKI H, Kato J, Horimoto K, Sato S, et al
    Delayed-onset abscopal effect after palliative radiotherapy for acral melanoma treated with anti-PD-1 therapy.
    J Dermatol. 2022 Mar 30. doi: 10.1111/1346-8138.16380.
    PubMed    


  261. ZENG J, Wang D, Luo J, Li L, et al
    Mannan-binding lectin exacerbates the severity of psoriasis by promoting plasmacytoid dendritic cell differentiation via the signal transducer and activator of transcription 3-interferon regulatory factor 8 axis.
    J Dermatol. 2022 Mar 29. doi: 10.1111/1346-8138.16323.
    PubMed     Abstract available


  262. UCHIDA H, Kamata M, Egawa S, Nagata M, et al
    Impact of the COVID-19 pandemic on biologic treatment in psoriasis patients: A single-center retrospective study in Japan.
    J Dermatol. 2022 Mar 23. doi: 10.1111/1346-8138.16362.
    PubMed     Abstract available


  263. CHENG AY, Lan J, Lee CH
    Impaired Wnt/beta-catenin and protein patched homolog 1 signaling in extraocular sebaceous carcinoma: A clinical and histopathological study.
    J Dermatol. 2022 Mar 22. doi: 10.1111/1346-8138.16351.
    PubMed     Abstract available


  264. CUI R, Chen M, Li X, Wang Q, et al
    Assessment of four screening tools and retrieval of key questions to detect undiagnosed psoriatic arthritis in Chinese patients with psoriasis: A multicenter study.
    J Dermatol. 2022 Mar 22. doi: 10.1111/1346-8138.16355.
    PubMed     Abstract available


  265. SEO T, Miyauchi T, Kawakami T, Ujiie H, et al
    Human figure-shaped contact dermatitis due to the illustration on the inner surface of compression sleeves.
    J Dermatol. 2022 Mar 22. doi: 10.1111/1346-8138.16363.
    PubMed    


  266. KAN T, Tanaka A, Kanamoto M, Morioke S, et al
    Longitudinal prevalence of atopic dermatitis among freshmen at Hiroshima University between 2002 and 2019.
    J Dermatol. 2022 Mar 22. doi: 10.1111/1346-8138.16366.
    PubMed     Abstract available


  267. MAENO M, Tamagawa-Mineoka R, Arakawa Y, Masuda K, et al
    Facial discoid lupus erythematosus during dupilumab treatment for atopic dermatitis.
    J Dermatol. 2022 Mar 18. doi: 10.1111/1346-8138.16356.
    PubMed    


  268. MAKINO T, Kataoka K, Kitayama S, Mizawa M, et al
    Successful treatment with excimer laser for cutaneous lesion of sarcoidosis.
    J Dermatol. 2022 Mar 18. doi: 10.1111/1346-8138.16357.
    PubMed    


  269. CHAIYABUTR C, Jiamton S, Silpa-Archa N, Wongpraparut C, et al
    Retrospective study of psoriasis in people living with HIV: Thailand's experience.
    J Dermatol. 2022 Mar 15. doi: 10.1111/1346-8138.16352.
    PubMed     Abstract available


  270. ISHIDA T, Saito R, Takahagi S, Tanaka A, et al
    Case of presenile diffuse sebaceous hyperplasia treated with adapalene gel.
    J Dermatol. 2022 Mar 8. doi: 10.1111/1346-8138.16349.
    PubMed    


  271. MATSUSHIMA Y, Mizutani K, Iida S, Ichishi M, et al
    Severe skin inflammation leads to salivary gland atrophy and dysfunction.
    J Dermatol. 2022 Mar 7. doi: 10.1111/1346-8138.16334.
    PubMed     Abstract available


  272. ITO Y, Takeichi T, Nakagawa K, Tanahashi K, et al
    Case of ichthyosis with confetti caused by KRT10 mutation, complicated with multiple malignant melanomas.
    J Dermatol. 2022 Mar 6. doi: 10.1111/1346-8138.16348.
    PubMed    


  273. UCHIYAMA A, Fujiwara C, Inoue Y, Motegi SI, et al
    Real-world effectiveness and safety of baricitinib in Japanese patients with atopic dermatitis: A single-center retrospective study.
    J Dermatol. 2022 Mar 6. doi: 10.1111/1346-8138.16350.
    PubMed    


  274. UEHARA A, Endo Y, Kosaka K, Oka A, et al
    Case of recurrent cutaneous eosinophilic vasculitis with subcutaneous nodules in the early stage of the disease.
    J Dermatol. 2022 Mar 3. doi: 10.1111/1346-8138.16342.
    PubMed    


  275. KOREKAWA A, Nakajima K, Fukushi K, Nakano H, et al
    Three cases of drug-induced hypersensitivity syndrome associated with mRNA-based coronavirus disease 2019 vaccines.
    J Dermatol. 2022 Mar 3. doi: 10.1111/1346-8138.16347.
    PubMed     Abstract available


  276. LEE E, Lee S, Tashiro Y, Ogihara M, et al
    Sequential screening of biomarkers in a case of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms occurring with virus reactivation and autoimmune disease.
    J Dermatol. 2022 Mar 3. doi: 10.1111/1346-8138.16341.
    PubMed    


  277. IWANAGA A, Utani A, Koike Y, Okubo Y, et al
    Clinical Practice Guidelines for Pseudoxanthoma Elasticum Drafting Committee: Clinical Practice Guidelines for Pseudoxanthoma Elasticum Drafting Committee: Clinical Practice Guidelines for Pseudoxanthoma Elasticum Drafting Committee.
    J Dermatol. 2022;49:e91-e98.
    PubMed     Abstract available


  278. SAEKI H, Tsunemi Y, Arai S, Ichiyama S, et al
    English version of guidelines for the management of asteatosis 2021 in Japan.
    J Dermatol. 2022;49:e77-e90.
    PubMed     Abstract available


  279. MIYACHI Y, Yamasaki K, Fujita T, Fujii C, et al
    Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle-controlled, phase 3 study.
    J Dermatol. 2022;49:330-340.
    PubMed     Abstract available


  280. OTA M, Nobeyama Y, Fukuda T, Asahina A, et al
    Relationship between iodine-enhanced dual energy-computed tomographic findings and ultrasonographic findings for psoriatic arthritis.
    J Dermatol. 2022;49:368-373.
    PubMed     Abstract available


  281. KONO T, Miyachi Y, Kawashima M
    Reply to Comment on "Clinical significance of the water retention and barrier function-improving capabilities of ceramide-containing formulations: A qualitative review".
    J Dermatol. 2022;49:e124.
    PubMed    


  282. HIRANO Y, Iwata H, Tsujuwaki M, Mai S, et al
    Super-resolution imaging detects BP180 autoantigen in immunoglobulin M pemphigoid.
    J Dermatol. 2022;49:374-378.
    PubMed     Abstract available


  283. KANEDA E, Tonomura K, Kotobuki Y, Ueda-Hayakawa I, et al
    Case of anti-Mi-2 antibody-positive dermatomyositis with predictable onset before the development of muscle symptoms.
    J Dermatol. 2022;49:e104-e105.
    PubMed    


  284. IWASAWA O, Kamiya K, Komine M, Ohtsuki M, et al
    Case of atypical erythema multiforme following coronavirus disease 2019 vaccination.
    J Dermatol. 2022;49:e113-e114.
    PubMed    


  285. IWASAWA O, Kamiya K, Okada H, Komine M, et al
    A case of erythroderma with elevated serum immunoglobulin E and thymus and activation-regulated chemokine levels following coronavirus disease 2019 vaccination.
    J Dermatol. 2022;49:e117-e118.
    PubMed    


  286. KANATANI Y, Shinkuma S, Matsumoto Y, Mitsui Y, et al
    Recurrence of impetigo herpetiformis carrying compound heterozygous mutations in IL36RN after remission with secukinumab.
    J Dermatol. 2022;49:e108-e110.
    PubMed    


  287. HIROYASU S, Hiroyasu A, Mine M, Kotobuki Y, et al
    Case of pemphigoid nodularis with immunoglobulin (Ig)G deposition accompanied by postinflammatory hypopigmentation without IgG deposition on the same forearm.
    J Dermatol. 2022;49:e99-e101.
    PubMed    


  288. KURIYAMA Y, Shimizu A, Kanai S, Yokoyama Y, et al
    Focal palmoplantar keratoderma in a patient with the KRT6B mutation.
    J Dermatol. 2022;49:e111-e112.
    PubMed    


  289. HOSOKAWA Y, Kamiya T, Sugita S, Hida T, et al
    Primary cutaneous diffuse large B-cell lymphoma, leg type, of the face that appeared on pre-existing T-cell pseudolymphoma clinically resembling actinic reticuloid.
    J Dermatol. 2022 Mar 1. doi: 10.1111/1346-8138.16331.
    PubMed    


    February 2022
  290. OKUNE M, Okiyama N, Fukuzono M, Sasaki K, et al
    Development of systemic lupus erythematosus after dupilumab treatment in a case of atopic dermatitis.
    J Dermatol. 2022 Feb 27. doi: 10.1111/1346-8138.16322.
    PubMed     Abstract available


  291. NOGUCHI H, Matsumoto T, Kimura U, Hiruma M, et al
    Empiric antifungal therapy in patients with cutaneous and subcutaneous phaeohyphomycosis.
    J Dermatol. 2022 Feb 25. doi: 10.1111/1346-8138.16312.
    PubMed     Abstract available


  292. AKATSUKA T, Sakai Y, Toyama T, Morimura S, et al
    Cutaneous reactions after coronavirus disease 2019 vaccination: Summary of 20 Japanese cases.
    J Dermatol. 2022 Feb 25. doi: 10.1111/1346-8138.16335.
    PubMed    


  293. TSUCHIYA M, Hashimoto R, Arai K, Yoshida K, et al
    Psoriasiform dermatitis in a girl with ulcerative colitis receiving vedolizumab.
    J Dermatol. 2022 Feb 23. doi: 10.1111/1346-8138.16318.
    PubMed    


  294. OZAKI S, Ichiyama S, Ito M, Hoashi T, et al
    Real-world blood examination screening data before initiation of biologics for psoriasis patients.
    J Dermatol. 2022 Feb 22. doi: 10.1111/1346-8138.16333.
    PubMed     Abstract available


  295. HAYASHI D, Nakai K, Sowa-Osako J, Ohsawa M, et al
    Deranged integrin expression in the epidermis of pemphigoid nodularis and prurigo nodularis: Are they the same hyperproliferative state?
    J Dermatol. 2022 Feb 21. doi: 10.1111/1346-8138.16330.
    PubMed    


  296. UCHIDA S, Kawai K, Tsutsui Y, Yamazaki M, et al
    Felty syndrome in a patient with undiagnosed rheumatoid arthritis presenting with multiple cutaneous abscesses.
    J Dermatol. 2022 Feb 21. doi: 10.1111/1346-8138.16332.
    PubMed    


  297. KISHIMOTO M, Komine M, Kamiya K, Sugai J, et al
    Case of psoriasis with hepatitis B virus infection during tumor necrosis factor inhibitor treatment successfully treated with ixekizumab and tenofovir alafenamide fumarate.
    J Dermatol. 2022 Feb 20. doi: 10.1111/1346-8138.16320.
    PubMed    


  298. KAWAKAMI T
    Surgical procedures and innovative approaches for vitiligo regenerative treatment and melanocytorrhagy.
    J Dermatol. 2022 Feb 17. doi: 10.1111/1346-8138.16316.
    PubMed     Abstract available


  299. NAKAZAWA S, Phadungsakswasdi P, Kageyama H, Fukuchi K, et al
    Decreased serum level of suprabasin in patients with nickel allergy.
    J Dermatol. 2022 Feb 17. doi: 10.1111/1346-8138.16315.
    PubMed    


  300. NISHIOKA K, Koizumi A, Takita Y
    Seven cases of contact dermatitis due to stearyl alcohol contained in topical medications.
    J Dermatol. 2022 Feb 16. doi: 10.1111/1346-8138.16325.
    PubMed     Abstract available


  301. MITSUISHI T, Miyata K, Ando A, Sano K, et al
    Characteristic nail lesions in Kawasaki disease: Case series and literature review.
    J Dermatol. 2022;49:232-238.
    PubMed     Abstract available


  302. NAGAI-SANGAWA M, Fukunaga A, Takeuchi C, Nishiyama S, et al
    Beneficial screening of Fabry disease in patients with hypohidrosis.
    J Dermatol. 2022;49:308-312.
    PubMed     Abstract available


  303. MOCHIZUKI H, Anzawa K, Mochizuki T
    Genotyping of intraspecies polymorphisms of Sporothrix globosa using partial sequence of mitochondrial DNA.
    J Dermatol. 2022;49:263-271.
    PubMed     Abstract available


  304. MIYACHI M, Imamura-Ichigatani T, Ihara H, Ohga Y, et al
    Herpes simplex virus DNA testing by a loop-mediated isothermal amplification method for accurate clinical diagnosis and detection of mucosal viral shedding.
    J Dermatol. 2022;49:282-288.
    PubMed     Abstract available


  305. ZHOU S, Gu L, Shi Z, Gu L, et al
    A novel nomogram based on a retrospective study of 346 patients to predict the recurrence risk of condyloma acuminatum after 5-aminolevulinic acid photodynamic therapy.
    J Dermatol. 2022;49:272-281.
    PubMed     Abstract available


  306. NAKANISHI T, Kokubu H, Fujimoto N, Tanaka T, et al
    Detection rate of pustules in palmoplantar pustulosis with dermoscopy.
    J Dermatol. 2022;49:299-302.
    PubMed     Abstract available


  307. SHINTANI Y, Nishida E, Furuhashi T, Muramatsu S, et al
    Efficacy of bath-psoralen and ultraviolet A therapy for mycosis fungoides - retrospective analysis of 62 cases.
    J Dermatol. 2022;49:239-245.
    PubMed     Abstract available


  308. KAWAI K
    Preface to Journal of Dermatology special issue: Cutaneous lymphoma.
    J Dermatol. 2022;49:201.
    PubMed    


  309. CHAO JP, Lin JY, Chiang CY, Hsieh TS, et al
    Assessment of melanin distribution in epidermolysis bullosa simplex with mottled pigmentation: A case report.
    J Dermatol. 2022;49:e63-e64.
    PubMed    


  310. HARADA K, Hagiwara T
    Gardner-Diamond syndrome complicated with chronic urticaria successfully treated with antihistamine.
    J Dermatol. 2022;49:e75-e76.
    PubMed    


  311. SHIRATORI M, Ozawa T, Tsuruta D
    Syndactyly repair in Kindler syndrome.
    J Dermatol. 2022;49:e65-e66.
    PubMed    


  312. YAMADA A, Kawase M, Matsumoto T, Demitsu T, et al
    Papular acantholytic dyskeratosis in a male patient localized to the anogenital area mimicking condyloma acuminatum.
    J Dermatol. 2022;49:e57-e58.
    PubMed    


  313. FUJII S, Nobeyama Y, Mizuno S, Asahina A, et al
    A case of desmoplastic trichoepithelioma accompanied by pseudolymphoma.
    J Dermatol. 2022;49:e55-e56.
    PubMed    


  314. TSUTSUI Y, Kawai K
    Papular CD30(+) T-cell pseudolymphoma induced by S-1.
    J Dermatol. 2022;49:e48-e49.
    PubMed    


    January 2022
  315. WANG Q, Lu W, Luo Y, Tan M, et al
    Relationship between patient acceptable symptom state and disease scores in psoriasis.
    J Dermatol. 2022 Jan 25. doi: 10.1111/1346-8138.16299.
    PubMed     Abstract available


  316. PEH D, Wan Ahmad Kammal WSL, Beh PJ, Yong ACH, et al
    Correlation of whole blood hydroxychloroquine concentration with cutaneous lupus erythematosus and factors associated with it: First multicenter, cross-sectional analysis in Malaysia.
    J Dermatol. 2022 Jan 24. doi: 10.1111/1346-8138.16292.
    PubMed     Abstract available


  317. MUNEKATA Y, Kitamura S, Yanagi T, Shimano M, et al
    Dermoscopic features of aneurysmal dermatofibroma: A case report and review of the literature.
    J Dermatol. 2022 Jan 17. doi: 10.1111/1346-8138.16306.
    PubMed    


  318. KAWANO N, Shiratori T, Kawada A
    Case of molluscum contagiosum of an aged female in association with the use of upadacitinib.
    J Dermatol. 2022 Jan 17. doi: 10.1111/1346-8138.16307.
    PubMed    


  319. HATTORI N, Koike Y, Murota H
    Treatment with an interleukin-17 inhibitor resulted in complete remission of psoriasis and flare-up of atopic dermatitis.
    J Dermatol. 2022 Jan 17. doi: 10.1111/1346-8138.16308.
    PubMed    


  320. ENDO Y, Kim J, Uchiyama A, Yasuda M, et al
    Spontaneous pneumomediastinum developed after steroid pulse therapy in diffuse cutaneous systemic sclerosis patient: A case report.
    J Dermatol. 2022 Jan 11. doi: 10.1111/1346-8138.16305.
    PubMed    


  321. ZHAO L, Wang C, Zhang Y, Li J, et al
    Whole-exome sequencing identified a novel pathogenic mutation of the CYP4F22 gene in a Chinese patient with autosomal recessive congenital ichthyosis and in vitro study of the mutant CYP4F22 protein.
    J Dermatol. 2022 Jan 11. doi: 10.1111/1346-8138.16300.
    PubMed     Abstract available


  322. OHUCHI K, Amagai R, Tamabuchi E, Kambayashi Y, et al
    Fulminant type 1 diabetes mellitus triggered by coronavirus disease 2019 vaccination in an advanced melanoma patient given adjuvant nivolumab therapy.
    J Dermatol. 2022 Jan 10. doi: 10.1111/1346-8138.16304.
    PubMed    


  323. UCHIYAMA M
    Primary cicatricial alopecia: Recent advances in evaluation and diagnosis based on trichoscopic and histopathological observation, including overlapping and specific features.
    J Dermatol. 2022;49:37-54.
    PubMed     Abstract available


  324. WANG J, Yu L, Zhang S, Wang C, et al
    Successful treatment of Netherton syndrome with dupilumab: A case report and review of the literature.
    J Dermatol. 2022;49:165-167.
    PubMed     Abstract available


  325. KINOSHITA-ISE M, Sachdeva M
    Update on trichoscopy: Integration of the terminology by systematic approach and a proposal of a diagnostic flowchart.
    J Dermatol. 2022;49:4-18.
    PubMed     Abstract available


  326. KITAJIMA Y, Kume N, Tajima A, Tanizaki H, et al
    Spindle cell squamous cell carcinoma exhibiting a metaplasia to atypical fibroxanthoma.
    J Dermatol. 2022;49:e44-e45.
    PubMed    


  327. SLAWINSKA M, Biernat W, Lange M, Nowicki RJ, et al
    Dermoscopy of Nanta nevus: A study of two cases.
    J Dermatol. 2022;49:e5-e6.
    PubMed    


  328. NAKAMURA M, Morita A
    Immune activity in Merkel cell carcinoma.
    J Dermatol. 2022;49:68-74.
    PubMed     Abstract available


  329. OHTSUKA T, Odagaki A, Akatsuka T
    Case of systemic sclerosis overlapping with neuromyelitis optica.
    J Dermatol. 2022;49:e40-e41.
    PubMed    


  330. NOGUCHI H, Matsumoto T, Kimura U, Hiruma M, et al
    Textbook case of onychomycosis caused by Scopulariopsis brevicaulis.
    J Dermatol. 2022;49:e38-e39.
    PubMed    


  331. LIM JW, Lee JH, Kim HJ
    Use of hydroxychloroquine in dermatology: A multicenter retrospective study in Korea.
    J Dermatol. 2022;49:173-178.
    PubMed     Abstract available


  332. FUKUYAMA M, Ito T, Ohyama M
    Alopecia areata: Current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines.
    J Dermatol. 2022;49:19-36.
    PubMed     Abstract available


  333. NIEBEL D, Wilhelmi J, De Vos L, Ziob J, et al
    Annular plaques mimicking Rowell's syndrome in the course of coronavirus disease 2019 mRNA vaccines: An overlooked phenomenon?
    J Dermatol. 2022;49:151-156.
    PubMed     Abstract available


  334. HAYASHI R, Shimomura Y
    Update of recent findings in genetic hair disorders.
    J Dermatol. 2022;49:55-67.
    PubMed     Abstract available


  335. KIRATIKANON S, Phinyo P, Rujiwetpongstorn R, Patumanond J, et al
    Adult-onset immunodeficiency due to anti-interferon-gamma autoantibody-associated Sweet syndrome: A distinctive entity.
    J Dermatol. 2022;49:133-141.
    PubMed     Abstract available


  336. EBATA S, Yoshizaki A, Fukasawa T, Yoshizaki-Ogawa A, et al
    Percentage of residual B cells after 2 weeks of rituximab treatment predicts the improvement of systemic sclerosis-associated interstitial lung disease.
    J Dermatol. 2022;49:179-183.
    PubMed     Abstract available


  337. MIYAKE T, Natsuga K, Umayahara T, Naito S, et al
    Case of inherited epidermolysis bullosa simplex with KLHL24 gene mutation in Japan.
    J Dermatol. 2022;49:e24-e25.
    PubMed    


  338. YOKOZEKI H, Fujimoto T, Wanatabe S, Ogawa S, et al
    Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: A randomized, double-blind, vehicle-controlled study.
    J Dermatol. 2022;49:86-94.
    PubMed     Abstract available


  339. OHATA M, Oda Y, Washio K, Fukunaga A, et al
    Efficacy of additional treatment for chronic spontaneous urticaria refractory to treatment - A single-center retrospective real-world study.
    J Dermatol. 2022;49:e7-e8.
    PubMed    


  340. TSUNEMI Y, Nakahigashi H
    Clinical study on the effects of the applied volume of moisturizer in patients with asteatosis.
    J Dermatol. 2022;49:75-85.
    PubMed     Abstract available


  341. KINOSHITA-ISE M, Fukuyama M, Ohyama M
    Distinctive age distribution and hair loss pattern putatively highlighting uniqueness of Japanese cases of fibrosing alopecia in a pattern distribution.
    J Dermatol. 2022;49:106-117.
    PubMed     Abstract available


  342. SAITO-SASAKI N, Sawada Y, Sato S, Sugino H, et al
    Possible beneficial impact of surgical deroofing procedure to cover the disadvantage of adalimumab treatment for hidradenitis suppurativa.
    J Dermatol. 2022;49:e3-e4.
    PubMed    


  343. ORITA A, Kitamura S, Maeda T, Yanagi T, et al
    Hidradenitis suppurativa successfully treated with two-stage surgery under disease control with adalimumab.
    J Dermatol. 2022;49:e1-e2.
    PubMed    


  344. SOGLIA S, Maione V, Bugatti M, Vermi W, et al
    Adalimumab for interleukin-1beta-mediated chronic non-scarring scalp folliculitis: Case report and literature review.
    J Dermatol. 2022;49:157-160.
    PubMed     Abstract available


    December 2021
  345. BABA A, Kanekura T, Tsubouchi H
    Lichenoid drug eruption after coronavirus disease 2019 vaccination.
    J Dermatol. 2021 Dec 27. doi: 10.1111/1346-8138.16294.
    PubMed    


  346. IKUMI K, Torii K, Sagawa Y, Kanayama Y, et al
    Phosphodiesterase 4 inhibitor apremilast improves insulin resistance in psoriasis patients.
    J Dermatol. 2021 Dec 27. doi: 10.1111/1346-8138.16286.
    PubMed    


  347. YONEKURA K
    Current treatment strategies and emerging therapies for cutaneous lymphoma.
    J Dermatol. 2021 Dec 27. doi: 10.1111/1346-8138.16289.
    PubMed     Abstract available


  348. WU R, Li X, Li S, Tang G, et al
    Decreased microRNA-126 expression in psoriatic CD4(+) T cells promotes T-helper 17 cell differentiation and the formation of dermatitis in imiquimod-induced psoriasis-like mice.
    J Dermatol. 2021 Dec 21. doi: 10.1111/1346-8138.16272.
    PubMed     Abstract available


  349. FUJII K
    Pathogenesis of cutaneous T cell lymphoma: Involvement of Staphylococcus aureus.
    J Dermatol. 2021 Dec 19. doi: 10.1111/1346-8138.16288.
    PubMed     Abstract available


  350. MIYAZAKI M, Ohkawa N, Miyabayashi K, Shoji H, et al
    Case of harlequin ichthyosis in preterm infant with a compound heterozygous ABCA12 missense mutation.
    J Dermatol. 2021 Dec 13. doi: 10.1111/1346-8138.16277.
    PubMed    


  351. INAZAWA-TERADA M, Namiki T, Omigawa C, Fujimoto T, et al
    An epidemiological survey of anhidrotic/hypohidrotic ectodermal dysplasia in Japan: High prevalence of allergic diseases.
    J Dermatol. 2021 Dec 13. doi: 10.1111/1346-8138.16278.
    PubMed     Abstract available


  352. COHEN-BARAK E, Mwassi B, Zagairy F, Danial-Farran N, et al
    Parental mosaic cutaneous-gonadal GJB2 mutation: From epidermal nevus to inherited ichthyosis-deafness syndrome.
    J Dermatol. 2021 Dec 9. doi: 10.1111/1346-8138.16268.
    PubMed     Abstract available


  353. SEO T, Kitamura S, Yanagi T, Ujiie H, et al
    Efficacy of a combination of paclitaxel and radiation therapy against cutaneous angiosarcoma: A single-institution retrospective study of 21 cases.
    J Dermatol. 2021 Dec 8. doi: 10.1111/1346-8138.16273.
    PubMed     Abstract available


  354. HIRANO Y, Kosumi H, Miyazawa H, Yanagi T, et al
    Toxic epidermal necrolysis induced by tirabrutinib.
    J Dermatol. 2021 Dec 5. doi: 10.1111/1346-8138.16274.
    PubMed    


  355. YATSUZUKA K, Murakami M, Kuroo Y, Fukui M, et al
    Flare-up of generalized pustular psoriasis combined with systemic capillary leak syndrome after coronavirus disease 2019 mRNA vaccination.
    J Dermatol. 2021 Dec 3. doi: 10.1111/1346-8138.16271.
    PubMed     Abstract available


  356. CHENG CY
    Risk of incident cataract in patients with psoriasis: A population-based cohort study.
    J Dermatol. 2021 Dec 3. doi: 10.1111/1346-8138.16261.
    PubMed     Abstract available


  357. CHUNG KB, Choi S, Bang D, Kim DY, et al
    Skin manifestation as an explaining factor of heterogeneity in Behcet's disease: A focused analysis in full-blown conditions.
    J Dermatol. 2021 Dec 3. doi: 10.1111/1346-8138.16250.
    PubMed     Abstract available


  358. YATSUZUKA K, Murakami M, Yoshida S, Utsunomiya R, et al
    Successful treatment of psoriasis vulgaris with apremilast in a patient with decompensated cirrhosis.
    J Dermatol. 2021 Dec 1. doi: 10.1111/1346-8138.16266.
    PubMed    


  359. ROGGENKAMP D, Sammain A, Furstenau M, Kausch M, et al
    Thiamidol((R)) in moderate-to-severe melasma: 24-week, randomized, double-blind, vehicle-controlled clinical study with subsequent regression phase.
    J Dermatol. 2021;48:1871-1876.
    PubMed     Abstract available


  360. ICHIKI N, Tawada C, Kato Z, Nakano H, et al
    Novel nonsense mutation in the SLC39A4 gene in a Japanese boy with mild acrodermatitis enteropathica.
    J Dermatol. 2021;48:e602-e603.
    PubMed    


  361. KONO T, Miyachi Y, Kawashima M
    Clinical significance of the water retention and barrier function-improving capabilities of ceramide-containing formulations: A qualitative review.
    J Dermatol. 2021;48:1807-1816.
    PubMed     Abstract available


  362. IKUMI N, Terui T, Fujita H
    Peripheral arthritis presenting pencil-in-cup deformity in a patient with palmoplantar pustulosis.
    J Dermatol. 2021;48:e612-e613.
    PubMed    


  363. YOTO A, Makino T, Mizawa M, Matsui Y, et al
    Two cases of Hailey-Hailey disease effectively treated with apremilast and a review of reported cases.
    J Dermatol. 2021;48:1945-1948.
    PubMed     Abstract available


  364. NOGUCHI H, Matsumoto T, Kimura U, Hiruma M, et al
    Ungual hyalohyphomycosis caused by Penicillium citrinum successfully treated with fosravuconazole.
    J Dermatol. 2021;48:e608-e609.
    PubMed    


  365. SAKAI H, Minami-Hori M, Shimamura T, Kanno K, et al
    Kawasaki disease in adolescence and adulthood: Report of four cases.
    J Dermatol. 2021;48:1940-1944.
    PubMed     Abstract available


  366. NAKAMURA K, Kosano M, Sakai Y, Saito N, et al
    Case of bullous pemphigoid following coronavirus disease 2019 vaccination.
    J Dermatol. 2021;48:e606-e607.
    PubMed    


  367. HASEGAWA A, Hayashi R, Shimomura Y, Hirashima M, et al
    Only plantar lesion of punctate palmoplantar keratoderma with a novel missense mutation in the AAGAB gene: Two Japanese familial case reports and review of reported mutations.
    J Dermatol. 2021;48:1926-1930.
    PubMed     Abstract available


  368. CHEN Y, Li Z, Song D, Wang S, et al
    Novel deletion of the POFUT1 gene associated with multiple seborrheic keratosis Dowling-Degos disease.
    J Dermatol. 2021;48:e591-e593.
    PubMed    


  369. WANG YA, Lee JY, Yang CC
    Sustainable effect of ultra-low dose rituximab for mild-to-moderate pemphigus vulgaris: A case report.
    J Dermatol. 2021;48:e583-e584.
    PubMed    


  370. OKUNO S, Hashimoto T, Satoh T
    Case of neuropathic itch-associated prurigo nodules on the bilateral upper arms after unilateral herpes zoster in a patient with cervical herniated discs: Successful treatment with mirogabalin.
    J Dermatol. 2021;48:e585-e586.
    PubMed    


  371. SHIBATA K, Kunisada M, Miyai S, Kawamori S, et al
    Incontinentia pigmenti in a female infant with somatic mosaicism due to the IKBKG variant.
    J Dermatol. 2021;48:e577-e578.
    PubMed    


  372. TAKENAKA M, Murota H, Nishimoto K
    Chronological evaluation of treatment effect for tinea unguium with efinaconazole: Possibility of an early estimation of treatment effects.
    J Dermatol. 2021;48:1923-1925.
    PubMed     Abstract available


  373. OKUBO Y, Morishima H, Zheng R, Terui T, et al
    Sustained efficacy and safety of guselkumab in patients with palmoplantar pustulosis through 1.5 years in a randomized phase 3 study.
    J Dermatol. 2021;48:1838-1853.
    PubMed     Abstract available


  374. SHIDO K, Kojima K, Yoshida-Akai S, Kikuchi K, et al
    Ehlers-Danlos syndrome type IV with a novel COL3A1 exon 14 skipping variation confirmed by Tohoku Medical Megabank Organization genomic database.
    J Dermatol. 2021;48:1918-1922.
    PubMed     Abstract available


    November 2021
  375. MIYAGAWA A, Adachi T, Kobayashi Y, Takamiyagi S, et al
    Plasmapheresis as a promising treatment option in apalutamide-associated toxic epidermal necrolysis.
    J Dermatol. 2021 Nov 26. doi: 10.1111/1346-8138.16248.
    PubMed    


  376. ASAKURA M, Yoshida K, Ishii M, Fujita H, et al
    Case of oral glycogenic acanthosis clinically resembling lichen planus.
    J Dermatol. 2021 Nov 26. doi: 10.1111/1346-8138.16259.
    PubMed    


  377. YONEKURA K, Ichiki M, Takeda K, Uchiyama N, et al
    Successful treatment of tumor stage mycosis fungoides with total skin helical tomotherapy.
    J Dermatol. 2021 Nov 21. doi: 10.1111/1346-8138.16246.
    PubMed     Abstract available


  378. HOLSKEN S, Krefting F, Schneider L, Benson S, et al
    A brief screening tool for depression in psoriasis patients: The Two Questions Test in clinical practice.
    J Dermatol. 2021 Nov 21. doi: 10.1111/1346-8138.16241.
    PubMed     Abstract available


  379. KASHIWADA-NAKAMURA K, Myangat TM, Kajihara I, Kanemaru H, et al
    Circulating Janus kinase family DNA levels in psoriasis: elevated JAK2 DNA copy number in cell-free DNA.
    J Dermatol. 2021 Nov 19. doi: 10.1111/1346-8138.16245.
    PubMed    


  380. SUNAGAWA K, Fukumoto T, Hamada T
    Invasive fusariosis presenting as multiple cutaneous nodules on the trunk and extremities.
    J Dermatol. 2021 Nov 16. doi: 10.1111/1346-8138.16239.
    PubMed    


  381. MYANGAT TM, Wada S, Sawamura S, Kajihara I, et al
    Microsatellite instability analysis using Promega panel in cutaneous squamous cell carcinoma.
    J Dermatol. 2021 Nov 14. doi: 10.1111/1346-8138.16238.
    PubMed    


  382. MAI S, Yanagi T, Shimano M, Nishie W, et al
    Case of hereditary leiomyomatosis and renal cell cancer showing multiple cutaneous leiomyomas harboring a recurrent nonsense mutation in the fumarate hydratase gene.
    J Dermatol. 2021 Nov 9. doi: 10.1111/1346-8138.16223.
    PubMed    


  383. HASHIZUME H, Ishikawa Y, Ajima S
    Is steroid pulse therapy a suitable treatment for drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms? A systematic review of case reports in patients treated with corticosteroids in Japan.
    J Dermatol. 2021 Nov 9. doi: 10.1111/1346-8138.16230.
    PubMed     Abstract available


  384. GOODERHAM MJ, Lynde C, Turchin I, Avadisian M, et al
    Real-world, long-term treatment patterns of commonly used biologics in Canadian patients with moderate-to-severe chronic plaque psoriasis.
    J Dermatol. 2021 Nov 7. doi: 10.1111/1346-8138.16214.
    PubMed     Abstract available


  385. FUJII K, Kanekura T
    Surgical excision: An option for a resectable lesion of cutaneous type adult T-cell leukemia/lymphoma.
    J Dermatol. 2021 Nov 7. doi: 10.1111/1346-8138.16221.
    PubMed    


  386. SAITO S, Endo Y, Nishio M, Uchiyama A, et al
    Anti-polymyositis/Scl antibody-positive overlap syndrome of diffuse cutaneous systemic sclerosis, dermatomyositis, systemic lupus erythematosus, and antiphospholipid syndrome.
    J Dermatol. 2021 Nov 3. doi: 10.1111/1346-8138.16219.
    PubMed     Abstract available


  387. YAMADA M, Nakano H, Ogita A, Saeki H, et al
    The second Japanese case of porphyria cutanea tarda with a novel genetic mutation in UROD.
    J Dermatol. 2021;48:1802-1803.
    PubMed    


  388. TOUBI E, Vadasz Z
    Predictive features associated with chronic spontaneous urticaria recurrence.
    J Dermatol. 2021;48:1786-1788.
    PubMed     Abstract available


  389. WU RW, Lin TK
    Oxford-AstraZeneca COVID-19 vaccine-induced acute localized exanthematous pustulosis.
    J Dermatol. 2021;48:e562-e563.
    PubMed    


  390. MAURELLI M, Bellinato F, Girolomoni G
    Adrenergic urticaria successfully treated with omalizumab.
    J Dermatol. 2021;48:e541-e542.
    PubMed    


  391. ONISHI Y, Arakawa Y, Tamagawa-Mineoka R, Ohshita A, et al
    Occurrence of palmoplantar pustulosis during atezolizumab therapy for non-small cell lung cancer.
    J Dermatol. 2021;48:e570-e571.
    PubMed    


  392. ZHOU X, Wang M, Wang S, Jiang X, et al
    Identification of novel compound heterozygous ITGB4 mutations in a Chinese woman with junctional epidermolysis bullosa without pylori atresia but profound urinary symptoms: A case report and review of the literature.
    J Dermatol. 2021;48:1780-1785.
    PubMed     Abstract available


  393. CHEN TL, Yip HT, Wang JH, Chang CH, et al
    Risk of chronic spontaneous urticaria in reproductive-aged women with abnormal uterine bleeding: A population-based cohort study.
    J Dermatol. 2021;48:1754-1762.
    PubMed     Abstract available


  394. USHIDA M, Arita T, Matsui M, Kanehisa F, et al
    Case of epidermodysplasia verruciformis with a novel mutation of TMC8.
    J Dermatol. 2021;48:e568-e569.
    PubMed    


  395. EGAWA K
    Familial occurrence of follicular keratosis of the chin.
    J Dermatol. 2021;48:1793-1796.
    PubMed     Abstract available


  396. ZHU R, Liu Y, Yan J, Tian Y, et al
    Overexpression of trefoil factor 1 and trefoil factor 3 in primary extramammary Paget's disease and implication of a novel therapeutic target.
    J Dermatol. 2021;48:e549-e550.
    PubMed    


  397. LEE SY, Lee KH, Ishii N, Hashimoto T, et al
    Rare case of bullous pemphigoid occurring on atrophic centers of disseminated superficial porokeratosis lesions.
    J Dermatol. 2021;48:e530-e531.
    PubMed    


  398. IKUMI N, Hayama K, Terui T, Kitamura N, et al
    Retrospective study of the differences in the management for pustulotic arthro-osteitis in patients with palmoplantar pustulosis between dermatologists and rheumatologists.
    J Dermatol. 2021;48:e551-e553.
    PubMed    


  399. OKU A, Nakai K, Ikenaga T, Sato K, et al
    Case of afatinib-induced severe purpuric drug eruption with gastrointestinal bleeding.
    J Dermatol. 2021;48:e534-e535.
    PubMed    


  400. KONDO N, Sakai Y, Kakutani R, Netsu T, et al
    Clinical characteristics and treatment status of pustulotic arthro-osteitis: A single-center study involving 51 cases.
    J Dermatol. 2021;48:1724-1730.
    PubMed     Abstract available


  401. HUANG Y, Yang J, Sun L, Zhang L, et al
    Efficacy of influential factors in hemoporfin-mediated photodynamic therapy for facial port-wine stains.
    J Dermatol. 2021;48:1700-1708.
    PubMed     Abstract available


  402. KAWAI T, Hayashi R, Yokoyama R, Abe R, et al
    Case of transient neonatal hyperpigmentation of the proximal nail fold.
    J Dermatol. 2021;48:e528-e529.
    PubMed    


  403. OHATA C, Tsuruta N, Yonekura K, Higashi Y, et al
    Clinical characteristics of Japanese pustular psoriasis: A multicenter observational study.
    J Dermatol. 2021 Nov 1. doi: 10.1111/1346-8138.16217.
    PubMed     Abstract available


    October 2021
  404. SONG WJ, Lim Y, Jo SJ
    De novo guttate psoriasis following coronavirus disease 2019 vaccination.
    J Dermatol. 2021 Oct 28. doi: 10.1111/1346-8138.16203.
    PubMed    


  405. SHIMODA-KOMATSU Y, Ida Y, Noda A, Oda M, et al
    Histological assessment of granuloma formation for the management of cutaneous Mycobacterium chelonae infection.
    J Dermatol. 2021 Oct 24. doi: 10.1111/1346-8138.16208.
    PubMed    


  406. SATO A, Takemori C, Fukumoto T, Aoyama N, et al
    Cutaneous leukocytoclastic vasculitis induced by thiamazole.
    J Dermatol. 2021 Oct 22. doi: 10.1111/1346-8138.16205.
    PubMed    


  407. LEE SJ, Lee A, Ishii N, Hashimoto T, et al
    Clinical outcome and B-cell kinetics in intercellular immunoglobulin A dermatosis treated with rituximab.
    J Dermatol. 2021 Oct 21. doi: 10.1111/1346-8138.16194.
    PubMed    


  408. BOCH K, Langan EA, Zillikens D, Ludwig RJ, et al
    Retrospective analysis of the clinical characteristics and patient-reported outcomes in vulval lichen planus: Results from a single-center study.
    J Dermatol. 2021 Oct 19. doi: 10.1111/1346-8138.16191.
    PubMed     Abstract available


  409. HAMADA T, Morita A, Suga H, Boki H, et al
    Safety and efficacy of bexarotene for Japanese patients with cutaneous T-cell lymphoma: Real-world experience from post-marketing surveillance.
    J Dermatol. 2021 Oct 18. doi: 10.1111/1346-8138.16201.
    PubMed     Abstract available


  410. LIU C, Gu L, Ding J, Meng Q, et al
    Autophagy in skin barrier and immune-related skin diseases.
    J Dermatol. 2021 Oct 16. doi: 10.1111/1346-8138.16185.
    PubMed     Abstract available


  411. CHAISUWANNARAK K, Chularojanamontri L, Junsuwan N, Eimpunth S, et al
    Cutaneous manifestations and dermoscopic findings are important clues to the diagnosis of Talaromyces marneffei in HIV patients with immune reconstitution inflammatory syndrome: A case report and literature review.
    J Dermatol. 2021 Oct 15. doi: 10.1111/1346-8138.16197.
    PubMed     Abstract available


  412. HUANG Y, Liu J, Zhang X, Li Y, et al
    Patients with senile pruritus have a distinct skin microbiota and epidermal barrier in comparison with healthy controls.
    J Dermatol. 2021 Oct 11. doi: 10.1111/1346-8138.16153.
    PubMed     Abstract available


  413. LU L, Yu Y, Zhang J, Fan X, et al
    Incidental amelioration of bullous pemphigoid during ixekizumab treatment for psoriasis.
    J Dermatol. 2021 Oct 11. doi: 10.1111/1346-8138.16189.
    PubMed    


  414. MIYAHARA H, Okiyama N, Okune M, Konishi R, et al
    Case of anti-nuclear matrix protein 2 antibody-positive juvenile dermatomyositis preceded by linear cutaneous lupus erythematosus on the face.
    J Dermatol. 2021 Oct 8. doi: 10.1111/1346-8138.16192.
    PubMed    


  415. GOTO T, Kogure A, Kuwano Y
    Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with skin eruptions mimicking acute generalized exanthematous pustulosis.
    J Dermatol. 2021 Oct 8. doi: 10.1111/1346-8138.16190.
    PubMed    


  416. KONISHI R, Tanaka R, Inoue S, Ichimura Y, et al
    Evaluation of apremilast, an oral phosphodiesterase 4 inhibitor, for refractory cutaneous dermatomyositis: A phase 1b clinical trial.
    J Dermatol. 2021 Oct 3. doi: 10.1111/1346-8138.16179.
    PubMed     Abstract available


  417. RAIKER R, Pakhchanian H, Pham J, Phan K, et al
    Coronavirus disease 2019 complications in patients with hidradenitis suppurativa: A multicenter analysis.
    J Dermatol. 2021;48:1619-1621.
    PubMed    


  418. YAMAMOTO T, Aoyama Y
    Role of pro-inflammatory cytokines in the pathophysiology of herpes simplex virus superinfection in Darier's disease.
    J Dermatol. 2021;48:1607-1611.
    PubMed     Abstract available


  419. KAGE P, Simon JC, Treudler R
    Case of atopic eczema treated with dupilumab throughout conception, pregnancy, and lactation.
    J Dermatol. 2021;48:E484-E485.
    PubMed    


  420. DAINICHI T, Kaku Y, Izumi M, Kataoka K, et al
    Anti-BP230-type papular non-bullous pemphigoid with granular immunoglobulin G deposition at the papillary dermis.
    J Dermatol. 2021;48:E517-E519.
    PubMed    


  421. YAMAMURA K, Matsushita S, Shimaoka S, Kitazono M, et al
    Anorectal function preserving surgery with endoscopic submucosal dissection in patients with perianal extramammary Paget's disease.
    J Dermatol. 2021;48:E520-E521.
    PubMed    


  422. IWABUCHI C, Hino H, Shimada K, Kaneko H, et al
    Recurrent furunculosis by Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus USA300 clone in Tokyo: A report of two cases.
    J Dermatol. 2021;48:E522-E523.
    PubMed    


  423. KURIYAMA Y, Shimizu A, Oka H, Sato M, et al
    Erythema nodosum-like eruption in coronavirus disease 2019: A case report and literature review of Asian countries.
    J Dermatol. 2021;48:1588-1592.
    PubMed     Abstract available


  424. LIU KL, Tsai TL, Tsai WC, Tsai SF, et al
    Prenatal heavy metal exposure, total immunoglobulin E, trajectory, and atopic diseases: A 15-year follow-up study of a Taiwanese birth cohort.
    J Dermatol. 2021;48:1542-1549.
    PubMed     Abstract available


  425. KIM JW, Kim M, Kim M, Kim BR, et al
    Atypical presentation of herpes simplex virus infection in an immunocompromised patient.
    J Dermatol. 2021;48:E512-E513.
    PubMed    


  426. SUEZAWA M, Dainichi T, Kaku Y, Izumi M, et al
    Dipeptidyl peptidase 4 inhibitor-associated mucous membrane pemphigoid.
    J Dermatol. 2021;48:1584-1587.
    PubMed     Abstract available


  427. LEECHAROEN W, Thanomkitti K, Thuangtong R, Varothai S, et al
    Use of facial care products and frontal fibrosing alopecia: Coincidence or true association?
    J Dermatol. 2021;48:1557-1563.
    PubMed     Abstract available


  428. ARAKAWA H, Tanese K, Tanaka R, Murakami K, et al
    Efficacy of hydroxychloroquine for treating annular erythema associated with Sjogren's syndrome.
    J Dermatol. 2021;48:1526-1532.
    PubMed     Abstract available


  429. MUROTA H, Fujimoto T, Oshima Y, Tamada Y, et al
    Cost-of-illness study for axillary hyperhidrosis in Japan.
    J Dermatol. 2021;48:1482-1490.
    PubMed     Abstract available


  430. KOMATSU H, Umegaki-Arao N, Futei Y, Iwabuchi E, et al
    Two cases of acquired lymphangioma: Dermoscopic-histopathologic correlation between irregular vessels on lacunae.
    J Dermatol. 2021;48:E506-E507.
    PubMed    


  431. DIAS DE OLIVEIRA NF, Miyamoto D, Maruta CW, Aoki V, et al
    Recurrent erythema multiforme: A therapeutic proposal for a chronic disease.
    J Dermatol. 2021;48:1569-1573.
    PubMed     Abstract available


  432. ASANO N, Yasuno S, Hayashi R, Shimomura Y, et al
    Characterization of EDARADD gene mutations responsible for hypohidrotic ectodermal dysplasia.
    J Dermatol. 2021;48:1533-1541.
    PubMed     Abstract available


  433. WATANABE S, Iozumi K, Abe M, Ito Y, et al
    Clinical effectiveness of efinaconazole 10% solution for treatment of onychomycosis with longitudinal spikes.
    J Dermatol. 2021;48:1474-1481.
    PubMed     Abstract available


  434. GOTO M, Izumi K, Hatano Y
    Case of bullous pemphigoid positive for full-length BP180 ELISA accompanied by immunological reconstitution due to antiretroviral therapy for human immunodeficiency virus infection.
    J Dermatol. 2021;48:E490-E491.
    PubMed    


  435. MORI A, Shinkuma S, Mitsui Y, Ogawa K, et al
    Acral persistent papular mucinosis: A case report and summary of 24 Japanese cases.
    J Dermatol. 2021;48:1574-1578.
    PubMed     Abstract available


  436. ZHANG Y, Qin W, Wang H, Lin Z, et al
    Novel pathogenic variants in the RECQL4 gene causing Rothmund-Thomson syndrome in three Chinese patients.
    J Dermatol. 2021;48:1511-1517.
    PubMed     Abstract available


    September 2021
  437. HUANG HL, Xu HM, Liu YD, Shou DW, et al
    Fecal microbiota transplantation as a novel approach for the treatment of atopic dermatitis.
    J Dermatol. 2021 Sep 27. doi: 10.1111/1346-8138.16169.
    PubMed    


  438. KIDO-NAKAHARA M, Yokote G, Yoshida M, Furue M, et al
    Atopic Dermatitis Control Tool (ADCT): A useful tool for self-evaluation in patients with atopic dermatitis.
    J Dermatol. 2021 Sep 27. doi: 10.1111/1346-8138.16176.
    PubMed    


  439. ADACHI M, Adachi T, Yokota M, Ichimura C, et al
    A case of vancomycin-induced linear IgA bullous dermatosis with toxic epidermal necrolysis-like symptoms: Palmoplantar eruptions as a possible risk marker.
    J Dermatol. 2021 Sep 24. doi: 10.1111/1346-8138.16173.
    PubMed    


    June 2021
  440. OSADA A, Arimitsu T, Nakazaki H, Kin T, et al
    Severe drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms in a 1-month-old infant with trisomy 21.
    J Dermatol. 2021 Jun 28. doi: 10.1111/1346-8138.16042.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: